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LYSINE CATABOLISM AND IN VIVO SUBSTRATE SPECIFICITY OF D-AMINO ACID
DEHYDROGENASES IN PSEUDOMONAS AERUGINOSA PAO1

by

SAI MADHURI INDURTHI

Under the Direction of Chung-Dar Lu, PhD

ABSTRACT
Among multiple interconnected pathways for L-Lysine catabolism in pseudomonads, it
has been reported that Pseudomonas aeruginosa PAO1 employs the decarboxylase and the
transaminase pathways. However, knowledge of several genes involved in operation and
regulation of these pathways was still missing. Transcriptome analyses coupled with promoter
activity measurements and growth phenotype analyses led us to identify new members in L-Lys
and D-Lys catabolism and regulation, including gcdR-gcdHG for glutarate utilization, dpkA,
amaR-amaAB and PA2035 for D-Lys catabolism, lysR-lysXE for putative L-Lys efflux and lysP
for putative L-Lys uptake. The amaAB operon is induced by L-Lys, D-Lys and pipecolate
supporting the convergence of Lys catabolic pathways to pipecolate. Growth on pipecolate was
retarded in the gcdG and gcdH mutants, suggesting the importance of glutarate in pipecolate and

2-aminoadipate utilization. Furthermore, this study indicated links in control of interconnected
networks of lysine and arginine catabolism in P. aeruginosa.
Effect of D-amino acids and the genes involved in their metabolism are of great interest
in both bacteria and mammals. D-Arg utilization in PAO1 requires the coupled dehydrogenases
DauB and DauA. In this study, DauB was found to use only L-Arg as its substrate unlike its
partner dehydrogenase DauA with wide substrate specificity. However, evidence from this study
and previous studies suggest that the coupled enzymes DauB and DauA are unique for D-Arg
catabolism.
The three D-amino acid dehydrogenases DguA, DadA and DauA were found to have
somewhat limited in vivo substrate specificity compared to that found in vitro tested using
purified enzymes. Many studies showed that D-amino acids are toxic to bacteria. The ΔdguA,
ΔdadA and ΔdauA triple mutant had two-fold lower minimum inhibition concentration of
carbenicillin and tetracycline compared to wild-type PAO1. Both in the wild-type PAO1 and the
triple mutant, synergy was observed between gentamicin or tetracycline (at concentrations below
the MIC) and D-amino acids resulting in growth inhibition or reduction, respectively. However,
no special synergistic or antagonistic effects were observed specifically in the ΔdguA, ΔdadA
and ΔdauA triple mutant as compared to the wild-type PAO1 when D-amino acids were given in
combination with antibiotics.
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1

GENERAL INTRODUCTION

Pseudomonas aeruginosa is a Gram-negative opportunistic human pathogen found widely in the
environment. It can cause mild infections in healthy individuals and serious life-threatening
infections in hospitalized patients with low immunity. Its metabolic versatility helps the bacterium
to thrive in different environments (58). Pseudomonads are known for their ability to utilize a
number of organic compounds as carbon and nitrogen sources due to the presence of a large
number of catabolic pathways. Understanding the regulation of these catabolic pathways helps
gain insight into the strategies employed by this pathogen to survive in human hosts under
conditions of varied nutrient availability and cause disease.

1.1

L-Lysine catabolism in P. aeruginosa

Unlike other pseudomonads, P. aeruginosa cannot utilize Lysine efficiently as a nutrient source.
Multiple and interconnected catabolic pathways exist for the utilization of lysine in microbes. As
shown in Figure 1.1, L-lysine is catabolized via the monooxygenase pathway in Pseudomonas
putida, while in P. aeruginosa it is mainly mediated via the decarboxylase pathway (5, 49, 51).
Expression of the lysine decarboxylase LdcA was found inducible by the arginine regulator ArgR
and L-arginine but not L-lysine in P. aeruginosa PAO1 (5), making this initial step in the proposed
pathway as a bottleneck for L-Lysine catabolism in this organism. Cadaverine, the product of
LdcA, is further degraded to 5-aminovalerate through the γ-glutamylation pathway for polyamine
catabolism that is controlled by PauR (7, 65). Both monooxygenase and decarboxylase pathways
converge at 5-aminovalerate, which is then converted to glutarate by a pair of transaminase and
semialdehyde dehydrogenase enzymes encoded by the gabDT operon (7, 50). Glutarate is
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proposed to produce acetyl-CoA that can enter the Krebs cycle (42), and glutaryl-CoA
dehydrogenase enzyme (an enzyme in glutarate catabolism) activity has been reported in crude
extracts of P. aeruginosa (15). However, none of the genes for glutarate catabolism and its
regulation have been characterized in Pseudomonas.

1.2

Lysine racemase and D-lysine catabolism in P. aeruginosa

The presence of a lysine (Lys) racemase has been reported in P. putida to convert L-Lys to D-Lys
(48, 49). The catabolic pathway for D-Lys catabolism in this organism (Figure 1.1) has been
proposed to degrade D-Lys to 2-aminoadipate, which is then further degraded to α-ketoglutarate
to enter the Krebs cycle. Several genes encoding enzymes of this proposed pathway in P. putida
KT2440 have been identified, including PP3590 for D-Lys transaminase, PP3596 for D-Lys
dehydrogenase, dpkA for Δ1-Piperideine-2-carboxylate reductase (38, 48, 49), amaB and amaA in
conversion of pipecolate to 2-aminoadipate (48). In the case of P. aeruginosa, it does not possess
the lysine racemase; however, L-Lys catabolism can potentially be connected to the D-Lys
pathway via an arginine-pyruvate transaminase AruH that can take L-Lys as substrate (5, 64). One
early report suggested the presence of another route through L-lysine 6-amino transferase to make
L-pipecolate which again could possibly convert into glutarate (15). In P. aeruginosa, the alpha
amino group of D-Lys can be deaminated by the FAD-dependent D-amino acid dehydrogenase
DauA (33). It was not clear how D-Lys catabolism was operated in this organism due to very
limiting information about potential players in the catabolic pathway.
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Figure 1.1 Lysine catabolism in P. aeruginosa PAO1 and P. putida KT2440.
Pathways in P. aeruginosa PAO1 and P. putida KT2440 were indicted in solid black arrows and
dashed gray arrows, respectively. Genes that are subjected to control by transcriptional regulators
ArgR, PauR, GcdR, DauR, and AmaR were labeled in different colors. LYS, lysine; CAD,
cadaverine; AMV, δ-aminovalerate; GA, glutaric acid; KAH, α-keto-ε-aminohexanoate (ketolysine); ΔP2C, Δ1-piperideine-2-carboxylate; L-PIP, L-pipecolate; ΔP6C, Δ1-piperideine-6carboxylate; 2-AAS, 2-aminoadipate semialdehyde; 2-AAP, 2-aminoadipate; 2-KAP, 2ketoadipate; α-KG, α-ketoglutarate.
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1.3

D-Amino acids in human health and disease

A few decades ago D-amino acids were not believed to be present in mammals, until large
amounts of free D-amino acids were detected in mammalian tissues (1). D-amino acids in
humans can be derived either by racemization of the cognate L-forms, from the food ingested or
from the intestinal normal flora (39). D-Serine (D-Ser) was shown to be associated with
neurotransmission, cell migration, and neurotoxicity. Elevated levels of D-Ser have been
detected in animal models of amyotrophic lateral sclerosis while a deficiency can trigger seizures
(54, 1). Also, D-Ser has been implicated to have a role in Alzheimer’s, a disease characterized by
a decline in learning and memory. The neuronal networks of the hippocampus, center for
memory, is affected by aging. Activation of N-Methyl-D-aspartate subtype of glutamate
receptors (NMDAR) which regulates the strength of synaptic transmission is affected by Dserine related pathways (like lack of racemase to convert L-serine to D-form) (2). Elevated levels
of D-Ser and D-Asp have implications in the possible development of Schizophrenia (1 & 13).

1.4

Significance of D-amino acids in bacteria

Amino acids exist as L and D-enantiomers. Proteins are composed of L-amino acids
predominantly. However, the D-amino acids are also part of living organisms and are important
for various cellular functions. Even though some D-amino acid containing peptides were
discovered in bacteria, the wider importance of D-amino acids was not well studied or understood
until a few decades ago (25). Recent studies showed that D-amino acids have important regulatory
roles in the bacterial world in addition to serving as growth nutrient, being incorporated into the
peptidoglycan layer (3) or inhibiting the bacterial spore germination (21). Many groups have
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demonstrated that D-amino acids can be detrimental to the cell. Certain D-amino acids like D-Met
were shown to be incorporated into the peptidoglycan and also inhibit peptidoglycan synthesis and
cross-linking (3). D-amino acids in combination with β-lactam antibiotics were reported to alter
cell morphology (4). Bacillus subtilis was shown to produce a mixture of D-Leu, D-Met, D-Tyr
and D-Trp to prevent biofilm formation and also disassemble biofilms (26). Lam et al, (28) found
unusual D-amino acids in Vibrio cholerae and Bacillus subtilis that seemed to modify the cell wall
in stationary phase cultures. Excess D-amino acids were shown to be released into the environment
and could serve as a means of communication to control and coordinate growth among the bacteria
living in that environment (26). D-amino acids given in combination with antimicrobials has a
synergistic effect on biofilm dispersal in some isolates of P. aeruginosa and Staphylococcus
aureus (52).

1.5

Bacterial biosynthesis of D-amino acids

L-amino acids being predominant in nature, serve as the substrates for D-amino acid biosynthesis
by racemization. Amino acid racemases are of two types: pyridoxal 5ʹ phosphate (PLP)
dependent and PLP independent enzymes. In the PLP dependent enzymes like the alanine and
serine racemases, the α-carbon of the amino acid is first deprotonated. The anionic form thus
formed is stabilized by the PLP moiety bound to the racemase after which the anionic form is reprotonated on the opposite side generating the other enantiomer of the same amino acid. In the
case of PLP independent enzymes like the glutamate and proline racemases, even though they
follow a similar mechanism as above they do not need a cofactor to stabilize the intermediate
carbanion (67, 4). In addition to racemization from L-to-D form, D-amino acids can also be
synthesized by D-amino acid transaminases using their respective keto acids and the amino
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group donated by D-alanine. In many gram-positive bacteria like Bacillus, Geobacillus and
Staphylococcal species D-glutamate (D-Glu) was found to be synthesized by D-amino acid
transaminase enzymes. (47, 16, 30). In P. aeruginosa, the arginine: pyruvate transaminase AruH
was shown to convert L-Lys to α-keto-ε-aminohexanoate (64, 5). This is one of the links
connecting the L- and D-Lys pathway in P. aeruginosa PAO1.

1.6

Degradation of D-amino acids in bacteria

D-amino acids can serve as a nutrient source to support bacterial growth when provided in
excess. Some organisms have genes to directly catabolize the D-amino acids while others require
them to be converted into the L-forms before they can be catabolized by enzymes like
transaminase and amidases (11, 12, 59). The first step in D-amino acid catabolism usually
involves D-amino acid oxidases, dehydrogenases or aminotransferases to remove the amino
group. The oxidase and dehydrogenase enzymes require cofactors like FAD+ or NAD+ as
electron acceptors while the aminotransferases or transaminases can directly transfer the amino
group from the α-amino acid to a α-keto acid (64, 31, 19, 35, 20).

1.7

D-amino acid catabolism in P. aeruginosa PAO1

P. aeruginosa has an enormous catabolic capacity to utilize a variety of D-amino acids as carbon
and/or nitrogen sources. As described below, five different enzymes have been reported to
facilitate the utilization of D-amino acids in this organism:

1.7.1

Arginine dehydrogenases, DauBA.

The utilization of D-arginine (D-Arg) in this organism is facilitated by the coupled arginine
dehydrogenases, DauA and DauB (31). DauA catalyzes oxidative deamination of D-Arg into 2-
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ketoarginine and ammonia. DauB then uses 2-ketoarginine and ammonia as substrates to convert
them into L-arginine (L-Arg) in the presence of NADPH or NADH (Figure 1.2). This D-to-L
racemization is an essential step for the utilization of D-Arg in this organism, taking advantage
of four different catabolic pathways of L-Arg. However, it is not known if these two enzymes
form a complex and if DauB also shares the wide substrate specificity of its partner enzyme
DauA. Mutation of dauA abolishes growth on both D-Arg (carbon and nitrogen source) and DLys (as nitrogen source) while mutation of dauB abolishes growth on D-Arg (as carbon source).
Enzymatic reactions using purified His-tagged protein showed that DauA can utilize a number of
D-amino acids as the substrate generating their respective keto-acid and ammonia, while the in
vitro substrate specificity of DauB is yet to be studied (31). In Chapter 2 of this study, we
characterized the DauB enzyme and studied its substrate specificity using purified enzyme.

Figure 1.2 Arginine racemization by DauBA.

1.7.2

D-alanine dehydrogenase, DadA.

The dadRAX locus encodes the genes for alanine (Ala) catabolism and regulation in P.
aeruginosa (19). DadX is an amino acid racemase that converts L-alanine to D-alanine while
DadA is a dehydrogenase that catalyzes the breakdown of D-alanine into pyruvate and ammonia
using FAD as a cofactor (see Figure 1.3). DadR is the transcriptional activator of dadAX operon
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in the presence of L-alanine. DadA can utilize all D-amino acids as the substrate except for DGlu and D-Gln as determined by the enzymatic reactions using purified His-tagged DadA.
However, in vivo studies using the dadA mutant revealed that only the utilization of Ala, His,
Phe, Ser, Thr and Val (all tested as a nitrogen source in glucose minimal medium) are dependent
on DadA (19).

Figure 1.3 Alanine racemization and catabolism by DadXA.

1.7.3

D-glutamate dehydrogenase, DguA.

The divergent dguR-dguABC gene cluster was shown to participate in D-Glutamate (D-Glu) and
D-Glutamine (D-Gln) catabolism and regulation (20). Both dguA and dguR mutants completely
lost the ability to grow on D-Glu and grew very poorly on D-Gln as the sole source of carbon or
nitrogen. DguR is the transcriptional activator of the dguABC operon in the presence of
exogenous D-Glu and D-Gln. The dguA gene encodes a FAD-dependent D-amino acid
dehydrogenase which deaminates D-Glu to generate α-ketoglutarate and ammonia in the
presence of FAD as the cofactor (Figure 1.4). The dguB gene encodes a putative enamine/imine
deaminase of the RidA family, but its role in D-Glu utilization is not known yet. The dguC gene
encodes a periplasmic solute-binding protein, but was found not essential for D-Glu utilization.
Instead, the acidic L-amino acid transported AatJQMP was found to be induced and essential for
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D-Glu utilization. Enzymatic assays using crude cellular extracts in vitro showed that DguA has
dehydrogenase activity against D-Glu, D-Pro, and D-Gln. (20).

Figure 1.4 D-Glutamate catabolism by DguA.

1.7.4

D-serine dehydratase, DsdA.

D-Serine dehydratase DsdA is an orphan gene in the genome of P. aeruginosa PAO1. This gene
has no regulatory elements resulting in no activation even in the presence of D-Ser. However,
when over expressed it can support the growth of PAO1 on D-Ser as the sole source of carbon
and nitrogen. Even though the D-alanine dehydrogenase DadA can utilize D-Ser as the substrate,
it can only support growth on D-Ser as nitrogen source but not as a carbon source. These two
enzymes have a very different enzymatic reaction. DsdA converts D-Ser into ammonia and
pyruvate while DadA converts it into ammonia and β-hydroxy pyruvate. The DsdA is a PLP
dependent enzyme (35). In E. coli, excess D-Ser can be toxic as it inhibits the biosynthesis of
pantothenate and L-Ser. Pantothenate is essential for the biosynthesis of coenzyme A (10). DsdA
rescues the cell from the effects of D-Ser by catabolizing it into pyruvate and ammonia. In E.
coli, the dsdCXA locus encodes for the D-serine deaminase (dsdA), the D-serine inner membrane
transporter (dsdX) and a divergently transcribed LysR-type transcriptional activator (dsdC). In
addition, transcriptional activation of dsdXA gene is subject to catabolite repression and requires
cyclic AMP and the cyclic AMP activator protein (37, 41).
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Figure 1.5 D-Serine catabolism by DsdA and DadA.

1.7.5

D-Hydroxyproline dehydrogenase, LhpBEF.

L-Hydroxyproline (L-Hyp), a non-proteingenic amino acid, is found in mammals and also in
bacteria. In mammals, it is formed by post-translational modifications by the action of prolyl 4hydroxylase and is an important constituent of collagen. In some bacteria, during the
biosynthesis of secondary metabolites like actinomycin and etamycin, L-Hyp is synthesized from
L-proline (29). L-Hyp can serve as a good carbon and nitrogen source in P. aeruginosa. This
requires the L-Hyp to be converted into D-Hyp first by the epimerase LhpA. Then the D-Hyp is
oxidized by the D-Hyp dehydrogenase LhpBEF into Δ1-pyrroline-2-carboxylate reductase and
subsequently into α-ketoglutarate by the deaminase LhpC and aldehyde dehydrogenase LhpG
(62, 34).

1.8

Research Strategy

My research project was focused mainly on identifying the missing players in Lysine utilization
in P. aeruginosa. Previous research from our lab showed that L-Lysine is catabolized via the
decarboxylase pathway to yield cadaverine which then is converted into 5-aminovalerate via the
γ-glutamylation pathway followed by its conversion into glutarate. Even though glutarate is
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believed to be catabolized to yield intermediates of the Krebs cycle, the key players in this
pathway are not known yet. In P. aeruginosa, the genes in D-lysine catabolic pathway and its
connections to the L-lysine catabolism are far from being clear. This is the first report to identify
the genes involved in glutarate catabolism, their regulation and also show that the D- and LLysine pathway are indeed connected in P. aeruginosa PAO1. All this work is discussed in
Chapter 2.

Previous studies from our lab showed that racemization by the coupled DauA and DauB
reactions is essential for D-arginine utilization in P. aeruginosa PAO1. They also showed that
DauA, a catabolic D-arginine dehydrogenase, exhibits a wide substrate specificity in in vitro
enzymatic studies. However, the DauB enzyme, an anabolic L-arginine dehydrogenase, has not
been characterized. It is also not known if DauB reciprocates the substrate specificity exhibited
by its partner dehydrogenase DauA. In this dissertation, we characterized the DauB enzyme and
studied its substrate specificity as discussed in Chapter 3.

Even though the three known D-amino acid dehydrogenases (DauA, DadA, and DguA) were
characterized previously, their substrate specificity in vitro and the effect of these respective
mutants in the utilization of various D-amino acids differ greatly. This is possibly due to
substrate redundancy as demonstrated by in vitro enzymatic studies. In order to identify the true
or in vivo substrate specificity of each of these dehydrogenase enzymes, we designed a study.
We constructed a triple mutant strain devoid of all these three known dehydrogenases discussed
above and verified the utilization of various D-amino acids as the sole carbon and or nitrogen
sources by complementing one dehydrogenase gene at a time. Further, as discussed above, the
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availability of D-amino acids from nature is scarce and emerging research shows that D-amino
acids have various regulatory roles. We also tested the hypothesis that the triple mutant devoid of
three D-amino acid dehydrogenases will be more sensitive to antibiotics in the presence of Damino acids. All this work is discussed in Chapter 4.
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2

MOLECULAR CHARACTERIZATION OF LYSR-LYSXE, GCDR-GCDHG, AND
AMAR-AMAAB OPERONS FOR LYSINE EXPORT AND CATABOLISM: A
COMPREHENSIVE LYSINE CATABOLIC NETWORK IN PSEUDOMONAS
AERUGINOSA PAO1

This work was partially published by Sai Madhuri Indurthi, Han-Ting Chou and Chung-Dar Lu in
“Molecular Characterization of lysR-lysXE, gcdR-gcdHG, and amaR-amaAB Operons for Lysine
Export and Catabolism: A Comprehensive Lysine Catabolic Network in Pseudomonas aeruginosa
PAO1”. Microbiology. 2016 May; 162(5):876-88.
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2.1

Introduction

P. aeruginosa is a Gram-negative opportunistic human pathogen found widely in the environment.
It can cause mild infections in healthy individuals and serious life-threatening infections in
hospitalized patients with low immunity. Its metabolic versatility helps the bacterium to thrive in
different environments (58). Pseudomonads are known for their ability to utilize a number of
organic compounds as carbon and nitrogen sources due to the presence of a large number of
catabolic pathways. Understanding the regulation of these catabolic pathways helps gain insight
into the strategies employed by this pathogen to survive in human hosts under conditions of varied
nutrient availability and cause disease.

2.1.1

L-lysine catabolism:

P. aeruginosa cannot utilize Lysine efficiently as a nutrient source (8). It was reported that this
organism employs the decarboxylase pathway for L-lysine catabolism. The expression of the
lysine decarboxylase LdcA is inducible by the arginine regulator ArgR and L-arginine but not by
L-lysine in P. aeruginosa PAO1 (5), making this initial step in the proposed pathway a bottleneck
for L-Lysine catabolism in this organism. Cadaverine, the product of LdcA, is further degraded to
5-aminovalerate through the γ-glutamylation pathway for polyamine catabolism (7, 66). Then 5aminovalerate is converted to glutarate by 4-aminobutyrate transferase and succinatesemialdehyde transferase enzymes (7, 50). Glutarate is proposed to be converted into acetyl-CoA
that can enter the Krebs cycle (42), and glutaryl-CoA dehydrogenase enzyme (an enzyme in
glutarate catabolism) activity has been reported in crude extracts of P. aeruginosa (15). However,
none of the genes for glutarate catabolism and its regulation have been characterized in
Pseudomonas. In addition to this, the genes for lysine uptake are also not known.
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2.1.2

D-lysine catabolism:

P. aeruginosa can utilize D-Lys only as a nitrogen source but not as a carbon source. In the case
of P. putida which can utilize D-Lys as a carbon and nitrogen source, D-Lys catabolism was
reported to be mediated by the aminoadipate pathway converting it into 2-aminoadipate and further
into α-ketoglutarate to enter the Krebs cycle. In addition, the presence of a lysine racemase has
been reported in P. putida to convert L-Lys to D-Lys (49, 51) making the aminoadipate pathway
an alternate to L-Lys catabolism. In the case of P. aeruginosa, it does not possess the lysine
racemase; however, L-Lys catabolism can potentially be connected to the D-Lys pathway via an
arginine: pyruvate transaminase AruH (5, 64). L-Lys can also be taken up by L-lysine 6-amino
transferase to make L-pipecolate (L-Pip) which again could convert into glutarate (15). In P.
aeruginosa, the FAD-dependent D-amino acid dehydrogenase DauA can deaminate the alpha
amino group of D-Lys (33). It was not clear how D-Lys catabolism was operated in this organism
due to very limiting information about potential players in the catabolic pathway.

2.1.3

Research Strategy

Many of the intermediate compounds in the proposed lysine catabolic pathways in P. aeruginosa
PAO1 can serve as better sources of carbon and nitrogen than lysine itself. It was known that lysine
catabolism is composed of multiple modules of biochemical reactions, and the expression of each
module is controlled by a specific intermediate compound and its corresponding regulators. To
gain a better understanding of the interconnections of L-Lys and D-Lys catabolism in P.
aeruginosa, we conducted transcriptome analysis to identify several possible missing links and
new players, and these thus identified members were subjected to further characterization to tie in
their physiological functions and regulatory mechanisms into an integrated metabolic network.
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2.2

Materials and methods
2.2.1

Strains and growth conditions.

Bacterial strains used in this study were listed in Table 2.1. Luria–Bertani (LB) medium was used
for bacterial growth with the following supplements as required: ampicillin at 100 µg/ml and
carbenicillin at 100 µg/ml for both E. coli and P. aeruginosa. Minimal medium P (MMP)
supplemented with specific carbon sources and nitrogen sources was used for the growth of P.
aeruginosa (16). Unless specified, mutant strains with a single lesion by transposon insertion used
in this study (Table 2.1) were obtained from the stock center at University of Washington, Seattle
(24).

Table 2.1 Bacterial strains and plasmids used in this study.
Strain or
plasmid
E. coli
DH5α

TOP10

Genotype or description

Source or reference

F– Φ80lacZΔM15 Δ(lacZYA-argF)

Bethesda

U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44
λ– thi-

Research

1 gyrA96 relA1
F– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15

Laboratories
Invitrogen

ΔlacX74 recA1araD139 Δ(ara leu) 7697 galU galK
rpsL
(StrR) endA1 nupG
P. aeruginosa
PAO1
PW1815
PW1817
PW1819
PW2858
PW2859
PW2862
PW3259
PW4475

Wild type
gcdG-F01::ISlacZ/hah
gcdH-A02::ISphoA/hah
gcdR-C02::ISphoA/hah
PA1026-G12::ISphoA/hah
amaA-E05::ISphoA/hah
amaB-B10::ISlacZ/hah
dpkA-D05::ISphoA/hah
dhcR-G02::ISlacZ/hah

(18)
(24)
(24)
(24)
(24)
(24)
(24)
(24)
(24)
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PW4478
PW4480
PW4481
PW4520
PW8087
PW8089
PW8366
PW8368
PW8370
PW9274
PW9379
PW9381
PW9382
PAO5720
PAO501
PAO5508
PAO5509
MJ 27
MJ 99

atoB::ISlacZ/hah
PA2002-D03::ISlacZ/hah
bdhA-H08::ISphoA/hah
PA2035-D05::ISphoA/hah
PA4181-F03::ISlacZ/hah
PA4182-B01::ISlacZ/hah
lysR-F10::ISphoA/hah
lysX-G02::ISlacZ/hah
lysE-A07::ISphoA/hah
amaR-E05::ISlacZ/hah
PA4979-G11::ISphoA/hah
PA4980-B07::ISphoA/hah
PA4981-C03::ISphoA/hah
aruH::Tcr
argR::Gmr
aruS::Tcr
aruR:: Tcr
Parental strain of MJ99
ΔdhcAB

Plasmids
pQF50
bla lacZ transcriptional fusion vector
pLYS 1-5
lysX::lacZ fusion of pQF50
pGCD 1-5
gcdH::lacZ fusion of pQF50
pAMA1-8
amaA::lacZ fusion of pQF50
pPA4181
PA4181::lacZ fusion of pQF50
pLYSP
lysP::lacZ fusion of pQF50
pBAD-HisE
Vector modified from pBAD-HisC
pGCDR-HisC 6His-tagged GcdR protein expression vector
pLYSR-HisC
6His-tagged LysR protein expression vector
pAMAR-HisC 6His-tagged AmaR protein expression vector
Tcr, tetracycline resistance; Gmr, gentamicin resistance

2.2.2

(24)
(24)
(24)
(24)
(24)
(24)
(24)
(24)
(24)
(24)
(24)
(24)
(24)
(5)
(44)
(65)
(65)
(61)
(61)

(14)
This study
This study
This study
This study
This study
(31)
This study
This study
This study

Transcriptome analysis.

Two independent sets of P. aeruginosa PAO1 cultures were grown aerobically in MMP media
with 10 mM L-Glu with 10 mM L-Lys, cadaverine (Cad), 5-amino valerate (AMV), glutaric acid
(GA), D-Lys or 5 mM L-pipecolate (L-Pip). Cells in the exponential growth phase were harvested,
and RNA samples were extracted from cells with RNeasy Plus Mini Kit (Qiagen). Following the
protocol of Affymetrix, cDNA was synthesized, fragmented, and labeled. Labeled cDNA was used
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for GeneChip Microarrays with P. aeruginosa Genome Array. Data were collected and analyzed
by comparing gene expression under each test condition to that by L-Glu following the same
parameters as described previously (6). Data were processed by Microarray Suite 5.0 software,
normalizing the absolute expression signal values of all chips to a target intensity of 500. Only
genes showing consistent expression profiles in duplicates were selected for further analysis. All
GeneChip data used by this study have been deposited in NCBI database (GEO accession number
GSE75502).

2.2.3

Construction of gene promoter::lacZ fusions.

For the construction of promoter lacZ fusions, the regulatory regions of the genes were amplified
from the genomic DNA of P. aeruginosa PAO1 by PCR with specific primer pairs as following:
GCD1-F and GCD1-R for pGCD1; LYS1-F and LYS1-R for pLYS1; AMA1-F and AMA1-R for
pAMA1; PA4181-F and PA4181-R for pPA4181; and LYSP-F and LYSP-R for pLYSP. Purified
PCR products were digested with specific restriction enzymes and ligated to pQF50 (13) digested
with the same enzymes before they were transformed into E. coli DH5α. The positive clones were
selected on LB plates containing ampicillin, and the nucleotide sequence of the inserts was
confirmed by DNA sequencing. Plasmids with serial deletions from the full-length inserts were
constructed by the same approach with specific primers.

2.2.4

Cloning, expression, and purification of hexahistidine-tagged LysR and
GcdR.

The structural genes of lysR, gcdR and amaR were amplified by PCR from the genomic DNA of
P. aeruginosa PAO1 using the following primer pairs: LysR-F and LysR-R for lysR; GcdR-F and
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GcdR-R for gcdR; and AmaR-F and AmaR-R for amaR. The resulting PCR products were digested
with specific restriction enzymes and cloned into the expression vector pBAD-HisE (31) so that
the C-terminus of LysR, GdhR and AmaR was fused in-frame with the His6-tag while the Nterminus is preceded by a ribosome binding site and an arabinose-inducible promoter in the
plasmid. The resulting plasmids, pLYSR, pGCDR, and pAMAR were introduced into E. coli
Top10 (Invitrogen). For overexpression of LysR, GcdR and AmaR proteins, the recombinant
strains of E. coli were grown in LB medium containing ampicillin at 37 °C. For over expression,
0.2 % L-arabinose (w/v) was added to the culture when the OD600 was approximately 0.5-0.6.
After 4h of vigorous shaking at 18 °C, cells were harvested by centrifugation and stored at -80 °C
until use.

The cell pellets were suspended in phosphate buffer A (20 mM Na2HPO4, 0.5 M NaCl, 20 mM
imidazole, pH 7.5) with PMSF (1 mM) as a protease inhibitor and the cells were ruptured by an
Aminco French press. Cell debris was removed by centrifugation at 30,000 g for 30 min. The
supernatant was applied to a HisTrap HP column (GE Health Care), and the His-tagged LysR was
eluted at 20-60 % buffer B and His-tagged GcdR was eluted at 40-70 % buffer B (20 mM
Na2HPO4, 0.5 M NaCl, 1 M imidazole, pH 7.5). The target fractions were analyzed by SDSPAGE, pooled and concentrated using an Amicon Ultra-15 centrifugal filter unit (molecular mass
cut-off, 30 kDa; Millipore) to change the buffer to 20 mM Tris-HCl (pH 7.5). Protein concentration
was determined by the method of Bradford (27). In the case of AmaR, all the protein was in the
pellet fraction (insoluble), and nothing was eluted in the fractions collected from the nickel column
after purification.
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Table 2.2 Primers used in this study.
Primer name
GCD1-F
GCD1-R
LYS1-F
LYS1-R
AMA1-F
AMA1-R
PA4181-F
PA4181-R
LysR-F
LysR-R
GcdR-F
GcdR-R
AmaR-F
AmaR-R
LYSP-F
LYSP-R

2.2.5

Primer sequence
5ʹ-ATGCGGATCCGGGTCAGGGACAACTCCTCC-3ʹ
5ʹ-ATGCAAGCTTCCGGTCTCGCCCATCTCGCG-3ʹ
5ʹ-ATGCGGATCCGCAGGCGTTCCGGGGCACC-3ʹ
5ʹ-ATGCAAGCTTCCGTGGCGAAGGCGGCGGTCAG-3ʹ
5ʹ-ATGCGGATCCGTCGGCGTTC GCAGGGTG-3ʹ
5ʹ-ATGCGGATCCGCCCCTCCAGTCGCAC GCA-3ʹ
5ʹ-ATGCGGATCCGCGCAGGGACTCCAGCAGGT-3ʹ
5ʹ-ATGCAAGCTTGCGCTCTACGGCGCGGCCG-3ʹ
5ʹ-ATCTCATGATTTTGTTCGACTACAAGTTGCTCG CCGC-3ʹ
5ʹ-GGGGCCTGACACCCGCACCAAGCC-3ʹ
5ʹ-ATCTCATGAGACGCAAGATCCCTTCCACCG-3ʹ
5ʹ- GGGGCCCAGCCCGTTGGCCTCGC-3ʹ
5'-ATCGGATCCATGCTGAACAAACGCCGCCTGC-3'
5'-GGGAACCGGGCCGTGGCGCGTC-3'
5'-ATGCGGATCCCGCCCATCGCCTGTCCGGAA-3'
5'-ATGCAAGCTTCGCCGGAGCCCATGAACAGC-3'

Reference
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

Electrophoretic mobility shift assays (EMSA).

The DNA probes (2 ng) were allowed to interact with different concentrations of GcdR or LysR
in the reaction buffer containing 50 mM Tris-HCl (pH 7.5 or pH 8.5, respectively), 50 mM KCl,
1 mM EDTA, 5 % (v/v) glycerol, 4 mM dithiothreitol (DTT) and 200 µg/ml acetylated bovine
serum albumin. After incubation for 10 min at room temperature, 20 µl of each reaction mixture
was loaded on a polyacrylamide gel (6 %) in Tris/borate-EDTA buffer (pH 8.7). The gels were
stained with SYBR Gold solution (Invitrogen) for 20 min, washed twice with deionized H2O, and
scanned.
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2.3

Results
2.3.1

Transcriptome profiling.

Many of the intermediate compounds in the proposed lysine catabolic pathways in P. aeruginosa
PAO1 can serve as better sources of carbon and nitrogen than lysine itself. We hypothesized that
lysine catabolism is composed of multiple modules of biochemical reactions, and each module is
controlled by a specific intermediate compound and its corresponding regulatory mechanism at
the genetic level. To get a more detailed understanding of lysine catabolism and regulation, DNA
microarray experiments were conducted to get a snapshot of gene expression during exponential
growth phase in the wild type strain PAO1 grown in glutamate (L-Glu) minimal medium
supplemented with L-Lys, CAD, AMV, GA, D-Lys or L-Pip. The expression profiling under each
test condition was compared to that of L-Glu and the genes that displayed over three-fold induction
with significant signal levels in duplicates were selected for further analyses.

Listed in Table 2.3 is a selected group of genes that was subjected to more detailed characterization
in this study. Some genes that passed the initial screening parameters have been characterized in
our previous reports as members of the γ-glutamylation pathway for CAD and polyamine
catabolism (7, 66), and hence were intentionally omitted from the list. Therefore in this table, we
mainly focused on genes that are either new or less characterized members in the Lys metabolic
network. In particular, this study characterized three operons (lysXE-R, gcdHG-R and amaAB-R)
that play significant roles in Lys utilization in PAO1, apart from some other genes that are activated
by L-Lysine.
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Table 2.3 Genes selected from DNA microarray analysis for L-Lys catabolism.
PA ID*

Gene
Name
PA0446 gcdG
PA0447 gcdH

Glu
266
242

Signal Intensity§
L-Lys CAD AMV GA D-Lys L-Pip
1263 1698 2294 11738 615
2256
9746 7201 9183 19218 1572 4215

PA0448
PA1027

gcdR
amaA

115
139

83
1230

69
197

91
238

156
81

56
4858

58
6105

PA1028

amaB

75

483

231

144

136

2460

3521

PA1252
PA1998
PA1999

dpkA
dchR
dchA

113
126
54

205
284
72

465
351
215

279
322
371

105
165
7081

285
221
161

252
238
153

PA2000

dchB

63

156

380

624

5767

157

165

PA2001

atoB

101

165

175

259

3763

95

73

38

165

185

136

542

95

103

bdhA

137

402

411

375

1387

315

257

PA2035
PA4181
PA4182
PA4363

lysR

51
169
234
54

198
5721
8589
59

167
432
423
35

35
385
457
104

82
191
282
45

1659
344
276
65

2974
416
250
28

PA4364
PA4365
PA4914
PA4976

lysX
lysE
amaR
aruH

38
33
187
130

2448
2304
321
630

125
181
299
130

30
111
337
53

60
37
137
111

182
89
239
180

162
115
142
149

PA4981

lysP

38

5855

189

39

61

100

93

PA2002
PA2003

Description
Acyl-coA transferase
Glutaryl-coA
dehydrogenase
Transcriptional regulator
NAD-dependent aldehyde
dehydrogenase
FAD-dependent
oxidoreductase
L-malate dehydrogenase
Transcriptional regulator
Dehydrocarnitine CoA
transferase
Dehydrocarnitine CoA
transferase
Acetyl-CoA
acetyltransferase
Conserved hypothetical
protein
3-hydroxybutyrate
dehydrogenase
Probable decarboxylase
Hypothetical protein
Transcriptional factor
Inhibitor of chromosome
initiation IciA
Hypothetical protein
Lysine efflux permease
Transcriptional regulator
Arginine: pyruvate
transaminase
Amino acid permease

* The PA ID numbers were from the PAO1 genome annotation project
(WWW.pseudomonas.com).
§ GeneChip raw data were mean values of two independent sets of cultures.

2.3.2

Growth phenotypes.

Mutants of various genes under study were obtained from the transposon mutant library stock
center (University of Washington). These mutants were checked for growth on L-Lys, CAD,
AMV, GA, L-Pip or L-Arg as the sole source of carbon and nitrogen on minimal medium plates
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and the growth was recorded as in Table 2.4. In the case of glutarate which can only serve as a
carbon source, ammonium chloride (0.5 %) was included in the growth medium as the nitrogen
source.

Table 2.4 Growth phenotype of various P. aeruginosa knockout mutants.
PA ID

Strain

Genotype Transposon Growth with indicated supplement
direction§ L-Arg L-Lys CAD AMV GA L-Pip
PAO1
Wild-type
NA
++
++
++
++ ++ ++
PA0446
PW1815
gcdG
R
++
PA0447
PW1817
gcdH
R
++
PA0448
PW1819
gcdR
F
++
NT
PA1026
PW2858
R
++
++
++
++ ++ ++
PA1027
PW2859
amaA
R
++
+
++
++ ++
PA1028
PW2862
amaB
F
++
+
++
++ ++
PA1252
PW3259
dpkA
R
++
++
++
++ ++ NT
PA1998
PW4475
dhcR
R
++
++
++
++ ++ ++
PA2001
PW4478
atoB
F
++
++
++
++ ++ ++
PA2002
PW4480
R
++
++
++
++ ++ ++
PA2003
PW4481
bdhA
R
++
++
++
++ ++ ++
PA2035
PW4520
R
++
+
++
++ ++
PA4181
PW8087
F
++
++
++
++ ++ NT
PA4182
PW8089
R
++
++
++
++ ++ NT
PA4363
PW8366
lysR
F
++
+++
++
++ ++ NT
PA4364
PW8368
lysX
F
++
+++
++
++ ++ NT
PA4365
PW8370
lysE
F
++
+++
++
++ ++ NT
PA4914
PW9274
amaR
F
++
+
++
++ ++
PA4976
PAO5503 aruH
++
++
++
++ ++ NT
PA4979
PW9379
F
++
++
++
++ ++ NT
PA4980
PW9381
R
++
++
++
++ ++ NT
PA4981
PW9382
lysP
R
++
+/++
++ ++ NT
*MJ27
Wild-type
++
++
++
++ ++ ++
PA1999-2000 *MJ99
dhcAB
++
++
++
++ ++ ++
Cells from two independent colonies were grown in MMP with the compounds indicated as the
sole source of carbon and nitrogen (20 mM) except for GA (10 mM) where 0.5 % NH4Cl was
added as the nitrogen source. Aerobic growth at 37 °C was followed for 4 days and recorded as
follows under each growth condition: +++, better growth than wild-type PAO1;++, same growth
as wild-type PAO1;+, weaker growth than wild-type PAO1;+/2, very poor growth compared
with wild-type PAO1; 2, no growth even after 4 days. NT, Not tested; NA, not applicable.
Significant changes in the growth phenotype were marked in gray. The PW strains of transposon
insertion mutants were obtained from the University of Washington Pseudomonas stock center.
MJ27 and MJ99 were gifted by Dr. M. J. Wargo (University of Vermont).
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*PA ID numbers were from the PAO1 genome annotation project
(http://www.pseudomonas.com). †Transposon direction refers to the absolute direction of the
transposon and transcriptional direction of a strong internal promoter carried by the transposon in
the genome. F, forward; R, reverse. Forward is oriented parallel to increasing nucleotide base
number and PA gene annotation number.
‡MJ27 is the parental strain of MJ99 and the comparison is made between these two and not the
wild-type PAO1 above.

It was found that mutants of gcdG, gcdH or gcdR were completely defective for growth on L-Lys,
CAD, AMV, GA and L-Pip but grew normally on L-Arg. Based on the genome annotation, the
divergent gcdR-gcdHG operon (Figure 2. 4a) encodes a transcriptional regulator, the glutaryl-CoA
dehydrogenase, and a putative acyl-CoA transferase, respectively. The results of growth phenotype
analyses support the proposed functions of these genes in glutarate utilization. Surprisingly, it was
found that these mutants cannot grow on L-Pip that is the intermediate compound in D-lysine
catabolism and was proposed to be converted into 2-aminoadipate (Figure 1.1). The results would,
therefore, support the route for converting 2-aminoadipate into glutarate, but not α-ketoglutarate
as has been suggested by early reports (46, 49).

In the proposed pathway, conversion of L-Pip into 2-aminoadipate requires two sequential
reactions catalyzed by AmaB and AmaA. Indeed the amaA and amaB mutants were completely
defective for growth on L-Pip, supporting their role in L-Pip and hence D-Lys catabolism.
Furthermore, these two mutations also affected growth on L-Lys, suggesting the presence of a
metabolic flow that is branched out from L-Lys catabolism (Figure 1.1). A similar pattern of
growth phenotypes was also observed for the mutant of amaR encoding a putative transcriptional
regulator of the amaAB operon.
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Among genes that were induced specifically by L-lysine, PA4981 (lysP) encodes a putative amino
acid permease, and the lesion in this gene exhibited strong growth defect on L-Lys. We also
compared the growth phenotype of the lysP mutant and the wild-type strain PAO1 on glucose
minimal medium with different nitrogen sources, including ammonium, L-Arg, D-Arg, L-Lys, and
D-Lys. The apparent growth defect of the lysP mutant was observed with D-Lys and L-Lys but
not D-Arg and L-Arg. It suggested the significant role of LysP as a potential Lys transporter.

On the contrary, among all mutants tested, it was found that the lysR, lysX, and lysE mutants grew
better than the parental strain on L-Lys. The lysX gene codes for a protein of unknown function
while the lysE gene codes for a putative amino acid exporter of the LysE/ArgO family, showing
45% sequence identity to the arginine exporter ArgO and the lysine exporter LysO of E. coli (40,
45). Upstream of the lysXE operon, the divergent lysR gene was annotated as iciA (60) by the
genome project, and the encoding transcriptional regulator exhibited 41% sequence identity to
ArgP of E. coli in control of ArgO expression. As supported by other lines evidence described
below, the enhanced growth on L-Lys of the lysR mutant was very likely due to its activation effect
on lysXE expression.

2.3.3

Induction of the gcdHG promoter.

To study regulation of the gcdHG operon, a gcdH::lacZ transcriptional fusion plasmid (pGCD1;
Figure. 2.3a) was constructed and introduced into wild-type PAO1 as described in Materials and
Methods. The ability of various compounds to activate the gcdH promoter was tested. Consistent
with the results of GeneChip analysis (Table 2.3), a similar pattern of promoter induction by L-
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Lys, CAD, AMV, GA, D-Lys and L-Pip was observed in PAO1 harboring pGCD1 by
measurements of β-galactosidase activities (Figure 2.1).

Figure 2.1 Expression profile of the gcdH promoter in vivo.
The gcdH promoter activity was monitored by measuring β-galactosidase activity in the wild-type
(WT) PAO1 and its mutants harboring the pGCD1 plasmid. The cells were grown in L-Glu (10
mM) minimal medium in the presence of various compounds as indicated above (10 mM). Specific
activity values represent the mean ± SD of three measurements for each growth condition. L-Glu,
L-glutamate; L-Lys, L-lysine; CAD, cadaverine; AMV, 5-aminovalerate; GA, glutarate; D-Lys,
D-lysine; L-Pip, L-pipecolate.

Among compounds tested, exogenous glutarate exerts the strongest effect on promoter induction,
suggesting glutarate as the potential effector compound for promoter activation. To test this
hypothesis, the levels of gcdH promoter activation by glutarate were also measured in the gcdG
and gcdR mutants harboring pGCD1. In comparison to the level in the wild-type PAO1, this
promoter was activated more than five-fold higher in the gcdG mutant, which was expected to
accumulate glutarate inside the cell without the acyl-CoA transferase activity. On the contrary, this
promoter showed no sign of induction in the gcdR mutant (Figure 2.1). These results support the
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hypothesis of GcdR as the transcriptional activator of the gcdHG operon in response to glutarate
as the signal molecule.

2.3.4

DNA binding activity of GcdR.

The results of growth phenotype analysis and promoter measurements indicated the potential
function of GcdR as the transcriptional regulator of the gcdHG operon in glutarate catabolism.
Recombinant GcdR with a hexahistidine tag at its carboxyl terminus was expressed and purified
from a strain of E. coli as described in Materials and Methods. This recombinant GcdR was used
to demonstrate its interactions with the gcdH promoter region by electrophoretic mobility shift
assays (EMSA). As shown in Figure 2.2, GcdR forms nucleoprotein complexes with DNA
fragments covering the gcdHG promoter region carried by pGCD1. Although the presence of
glutarate in the binding reaction did not cause any change in affinity of GcdR to the probe DNA,
it seemed to favor nucleoprotein complexes that migrate slower on the gel in comparison to those
without glutarate.
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Figure 2.2 Demonstration of GcdR-DNA interactions.
The gcdH promoter regions as in pGCD1, pGCD3 or pGCD4 were used as the probe. The purified
GcdR-His(6) of the concentrations indicated was used with or without 5 mM glutaric acid (GA)
as indicated in each reaction. F, free probe; C, nucleoprotein complexes. Locations of free probes
and major nucleoprotein complexes are also marked with arrows.

In order to further narrow down the GcdR binding site, shorter probes carried by pGCD2, pGCD3,
pGCD4 and pGCD5 (Figure 2.3a) were generated and tested for interactions with GcdR (Figure
2.2). The result of serial deletions led us to identify a region of 30 bp that may carry the GcdR
operator site as described below. It was also supported by the promoter activity measurements
(Figure 2.3b) carrying the same series of promoter fragments as in the EMSA. Site-directed
mutagenesis of the proposed GcdR operator in pGCD4 or absence of the proposed GcdR operator
in pGCD5 resulted in complete abolishment of glutarate-dependent induction of the gcdH
promoter activity.
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2.3.5

Multiple sequence alignment of gcdHG promoters in Pseudomonas.

Information from comparative genomics indicated that gcdR-gcdHG genes are highly conserved
among various species of Pseudomonas (www.pseudomonas.com). Multiple sequence alignment
was conducted for the gcdHG regulatory regions from representative species which revealed a
highly conserved sequence motif. In accordance with the results of promoter analysis and gel shift
assays shown in Figure 2.1 and 2.2, it appeared that the sequence motif (5’GTGAGAAAATAGCAC-3’) 109 bp upstream of the gcdH initiation codon might be a potential
candidate of GcdR operator. A second conserved sequence motif was found downstream of the
proposed GcdR operator site (Figure 2.3d). However, this site was excluded as the GcdR operator
site as binding of GcdR to the pGCD1 probe was retained after digestion with the restriction
enzyme EcoRI, which is located in the middle of the second conserved sequence motif (data not
shown). Site-directed mutagenesis of the first three bases in the proposed GcdR operator from
GTG in pGCD3 to ACA in pGCD4 resulted in complete loss of GcdR binding in vitro (Figure 2.2)
and loss of promoter activation in vivo (Figure 2.1).
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Figure 2.3 Identification of GcdR binding site on the gcdH promoter region.
(a) Schematic presentations of the divergent gcdR-gcdGH operons and constructs of the
gcdH::lacZ fusions. Five plasmids of serial deletions in the regulatory regions were labeled with
plasmid names.
(b) Measurements of β-galactosidase activity from fusion plasmids and summary of GcdR binding
activity with the gcdH regulatory region carried by these plasmids. L-Glu, L-glutamate; GA,
glutaric acid. Binding of GcdR to the region was indicated by “+” signs and no binding was
indicated by “-“.
(c) The nucleotide sequence of the gcdH regulatory region. Locations of 5’-end for pGCD2,
pGCD3, pGCD4 and pGCD5 and ATG initiation codons for gcdH and gcdR were indicated with
arrow signs and labels. The -10 and -35 sequences for the putative promoter were also labeled.
The proposed GcdR operator site was in bold italicized letters with double underline. S.D., ShineDalgarno sequence for ribosomal binding.
(d) Multiple sequence alignments for the putative GcdR operators in the gcdH regulatory regions
of representative species of Pseudomonas in the following order: P. aeruginosa (PAO1), P.
denitrificans (ATCC13867), P. mendocina (NK01), P. fluorescens (Pf01), P. entomophila (L48),
P. stutzeri (CCUG29243), P. fulva (12-X), and P. putida (KT2440).
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2.3.6

Induction of lysXE by L-Lys.

As described above, lysE was proposed to encode the putative L-Lys exporter, and it forms a
putative operon with the upstream lysX of unknown function. To test the expression profiling of
lysXE, a lysX::lacZ transcriptional fusion plasmid (pLYS1) was constructed and introduced into
wild-type PAO1. The ability of various compounds to activate this promoter was tested. As shown
in Figure 2.4, it was found that this promoter was induced by L-Lys only, consistent with the
results of the DNA microarray experiments (Table 2.3).

Figure 2.4 Expression profile of the lysX promoter in vivo.
The lysXE promoter activity was monitored by measuring β-galactosidase activity in the wild-type
& mutant PAO1 harboring the pLYS1 plasmid. The cells were grown in L-Glu alone (20 mM) or
L-Glu + L-Lys (10 mM each) minimal medium. Specific activity values represent the mean ± SD
of three measurements for each growth condition. L-Glu, L-glutamate; L-Lys, L-lysine; CAD,
cadaverine; AMV, 5-aminovalerate; GA, glutarate; L-Arg, L-arginine.
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The activity of lysX promoter was also measured in various mutants in order to understand the
regulatory mechanism of the lysXE operon. It was found that lysine-dependent induction of the
lysX promoter was completely abolished in strain PW8366 carrying a lesion on lysR (Figure 2.4).
On the contrary, the level of induction by L-Lys in the lysX or lysE mutant was even higher than
that in the wild-type strain PAO1. These results supported the proposed functions of LysE and
LysR as L-Lys exporter and lysine-responsive transcriptional activator, and suggested a link of
LysX to the lysine export system.

2.3.7

DNA binding activity of LysR.

LysR was overexpressed and purified with a hexahistidine tag at its carboxyl terminus as described
in Materials and Methods. This recombinant LysR was used to demonstrate its interaction with the
lysX promoter region by EMSA. LysR alone was able to bind to a DNA fragment carrying the lysX
promoter region in pLYS1 to form nucleoprotein complexes (C1 and C2; Figure 2.5). We also
tested the potential effects of two amino acids, L-Lys and L-Arg, on LysR-DNA interactions.
However, only minimal effects can be detected by the presence of these two amino acids in vitro,
which cannot be explained for the observed effects in vivo.

In an attempt to identify the LysR operator sites, multiple sequence alignments were conducted
with the lysX promoter sequences from PAO1 and representative strains from different gene
clusters. As shown in Figure 2.6c, a conserved sequence motif was found in this regulatory region
that could potentially be the Lys operator site. This finding is further supported by the loss of LysR
binding in EMSA with lysX promoter DNA fragments lacking this motif in pLYS4 and pLYS5
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(Figure 2.6b) and also by the lack of transcriptional activation in these two plasmids in the presence
of L-Lys in the wild-type PAO1 in Figure 2.6b.

Figure 2.5 Demonstration of LysR-DNA interactions.
(a) Promoter DNA as in pLYS1 or pPA4181 was used as the probe. The purified LysR-His(6) of
indicated concentrations was used with or without 5 mM L-lysine (L-Lys) or L-arginine (L-Arg)
in the reaction.
(b) Promoter DNA as in pLYS2, pLYS3, pLYS4 or pLYS5 was used as the probe. All reactions
were carried out in the presence of 5 mM L-Lys. F, free probe; C1 and C2, nucleoprotein
complexes.
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Figure 2.6 Identification of LysR operator on the lysXE promoter region.
(a) Schematic presentations of the divergent lysR-lysXE operons and constructs of the lysX::lacZ
fusions. Five plasmids of serial deletions in the regulatory regions were labeled with plasmid
names.
(b) Measurements of β-galactosidase activity from fusion plasmids and summary of LysR binding
activity with the lysXE regulatory region carried by these plasmids. L-Glu, L-glutamate; L-Lys, Llysine. Binding of LysR to the region was indicated by “+” signs and no binding was indicated by
“-“.
(c) The nucleotide sequence of the lysXE regulatory region. Locations of 5’-end for pLYS3,
pLYS4, and pLYS5 and ATG initiation codons for gcdH and gcdR were indicated with arrow signs
and labels. The -10 sequence for the putative promoter were also labeled. The proposed LysR
operator site was in bold italicized letters with double underline.
(d) Multiple sequence alignments for the putative LysR operators in the lysXE regulatory regions
of representative species of Pseudomonas in the following order: P. aeruginosa (PAO1), P.
denitrificans (ATCC13867), P. mendocina (NK01), P. fluorescens (Pf01), P. entomophila (L48),
P. stutzeri (CCUG29243), P. fulva (12-X), and P. putida (KT2440). The proposed LysR site was
marked with divergent arrows. The ATG initiation codon for PAO1 was marked with double lines,
and single line with other species. The dashed line denotes the ribosomal binding site. Also shown
on the right side of this panel were the two types of gene organizations for lysine exporter and
transcriptional regulator in these species of Pseudomonas.
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2.3.8

Induction of the amaAB promoter.

From transcriptome analysis, amaAB of P. aeruginosa PAO1 was found inducible to a comparable
level by D-Lys and L-Pip. This operon was also induced by L-Lys but to a relatively low level. To
substantiate this finding, the amaA::lacZ transcriptional fusion plasmid (pAMA1) was constructed
and introduced into the wild type strain PAO1 to analyze the expression profiling of this promoter.
As shown in Figure 2.7, the amaA promoter was induced by L-Lys, D-Lys, and L-Pip, consistent
with the DNA microarray experiments (see Table 2.3).

Figure 2.7 Expression of the amaA promoter in vivo.
The amaA promoter activity was monitored by measuring β-galactosidase activity in the wild-type
and mutant PAO1 harboring the pAMA1 plasmid. The cells were grown in glutamate minimal
medium in the presence of various compounds as indicated above (10 mM). Specific activity
values represent the mean ± standard deviation of three measurements for each growth condition.
L-Glu, L-glutamate; L-Lys, L-lysine; D-Lys, D-lysine; L-Pip, L-pipecolate.
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Divergent from the amaAB operon, the PA1026 gene codes for a putative transcriptional
elongation factor of the GreA/GreB family (www.pseudomonas.com). However, the knockout
mutant of this gene grew normally on all compounds tested in this study (Table 2.4), and it did not
affect the expression profiling of the amaA promoter (data not shown). These results led us to
exclude PA1026 as the regulatory gene of amaAB. In the case of P. putida KT2440, the PP5259
gene encoding a transcriptional regulator of the LysR family was also divergently transcribed from
the amaAB operon in this bacterium (49). Based on sequence similarity we found PA4914 of PAO1
as the possible orthologue of PP5259. As shown in Figure 2.7, activation of the amaAB promoter
by L-Lys or D-Lys was lost completely in the PA4914 knockout mutant (PW9274) suggesting that
PA4914 is the transcriptional activator of the amaAB operon. We, therefore, designated PA4914
as amaR. Consistent with its role in activation of amaAB, the amaR mutant exhibited the same
pattern of growth defect on L-Lys and L-Pip as the amaA and amaB mutants (Table 2.4).

2.3.9

Induction of the amaAB operon by L-Lys was abolished in the PA1252
mutant.

Although L-Lys catabolism in P. aeruginosa PAO1 is mainly through the decarboxylase pathway,
it can also be channeled into the D-Lys pathway via the transaminase pathway (3). As shown in
Figure 1.1, L-Lys and D-Lys catabolism may converge at α-keto-ε-aminohexanoate (aka ketolysine), which then spontaneously cyclizes to form Δʹ-piperidine-2-carboxylate. This convergence
was further supported by our findings that L-Lys is able to induce the amaAB operon (Table 2.3
and Figure 2.7), which encodes enzymes for the subsequent degradation of Δʹ-piperidine-2carboxylate to 2-aminoadipate. One missing link in the converged pathway is the enzyme
converting Δʹ-piperidine-2-carboxylate to L-Pip. On potential candidate of this enzyme was
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encoded by the PA1252, based on its sequence homology to DpkA (PP3591) of P. putida KT2440
that has been previously shown to catalyze this reaction in D-Lys and D-Pro catabolism (25, 33).
From the results of transcriptome analysis (Table 2.3), the PA1252 gene was found not inducible
by L-Lys, D-Lys, or L-Pip. However, activation of the amaA promoter by L-Lys, and D-Lys was
completely lost in the PA1252 mutant (Figure 2.7), supporting its role in the conversion of Δʹpiperidine-2-carboxylate to L-Pip and thereby in Lys catabolism in PAO1.

2.3.10 DNA binding activity of AmaR and the potential AmaR operator site.
Even though the cloning and expression of AmaR-HisC were successful, the purification of this
protein was not successful. SDS-PAGE analysis showed that all the target protein is in the pellet
fraction (inclusion bodies) and none was seen in the fractions collected during purification. The
protein purification was repeated again under the same conditions. The collected fractions that
are free of other major proteins were pooled and checked on SDS-PAGE to see if there was any
small amount of AmaR-HisC. No protein was detected on the gel after staining. Since the
protein purification was not successful, the plan to test the DNA binding of AmaR was
dismissed. However, based on multiple sequence alignment of amaAB regulatory regions from
representative pseudomonas species, a potential AmaR binding site was identified (as shown in
Figure 2.8c). A total of eight plasmids of serial deletions were tested for the promoter activation
using β-galactosidase assay. However, we could not confirm the potential AmaR binding site
which was possibly disrupted in pAMA6 and hence had no promoter activation (see Figure 2.8b)
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Figure 2.8 Identification of AmaR operator on the amaAB promoter region.
(a) Schematic presentations of the amaAB operon and constructs of the amaA::lacZ fusions. A
total of eight plasmids of serial deletions in the regulatory regions were labeled with plasmid
names. (b) Measurements of β-galactosidase activity from fusion plasmids. (c) The nucleotide
sequence of the amaA regulatory region. Locations of the 5’ ends for pAMA2, pAMA3,
pAMA4, pAMA5, pAMA6, pAMA7, and pAMA8 are indicated by arrowheads and the ATG
initiation codon for amaA is underlined and bolded. (d) Multiple sequence alignment of amaA
regulatory regions of representative species P. aeruginosa (PAO1), P. syringae (BRIP39023), P.
fluorescens (AU1382) and P. putida (KT2440).
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2.3.11 The PA4181-PA4182 operon of unknown functions was inducible by L-Lys.
The putative PA4181-PA4182 operon was identified from transcriptome analysis as genes
specifically induced by L-Lys (Table 2.3). To substantiate this finding, the PA4181::lacZ fusion
plasmid (pPA4181) was constructed and introduced into wild-type PAO1. The ability of various
compounds to activate this promoter was tested. It was found that this operon was induced by LLys only (Figure 2.9) consistent with the DNA microarray experiments. Genome annotations
suggested the presence of a B3/B4 tRNA-binding domain in the PA4181 peptide, and the PA4182
peptide was predicted as transcriptional factor with an FMN-binding domain. To test if the
induction effect of L-Lys on the PA4181 promoter depends on PA4182 or lysR, the pPA4181
plasmid was introduced into the PA4181 and lysR mutants to measure the promoter activities. The
results showed that promoter activation of pPA4181 by L-Lys was completely lost in the lysR
mutant indicating that lysR is the transcriptional activator of this operon. The promoter region of
PA4181 carried by the pPA4181 plasmid was used as the probe to test the binding of lysR as
described in Materials & Methods. Indeed purified His-tagged LysR did bind to this DNA probe
of PA4181 as shown in Figure 2.5a, confirming the results of promoter activation experiments
(Figure 2.9). Similar to results with the lysE probe, at least two nucleoprotein complexes (C1 and
C2) can be observed by EMSA, and the addition of L-Lys to the binding reaction also led to the
preferential formation of C1 complex (Figure 2.5a).
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Figure 2.9 Expression of the PA4181 promoter in vivo.
The promoter activity of PA4181was monitored by measuring β-galactosidase activity in the wildtype & mutant PAO1 harboring the pPA4181 plasmid. The cells were grown in glutamate minimal
medium in presence of various compounds as indicated above (10 mM). Specific activity values
represent the mean ± standard deviation of three measurements for each growth condition. L-Glu,
L-glutamate; L-Lys, L-lysine; CAD, cadaverine; AMV, 5-aminovalerate; GA, glutaratic acid.

2.3.12 Induction of lysP promoter.
The lysP is an orphan gene next to the aruSR two component system on the P. aeruginosa
genome. This gene was found to be induced by L-Lys during transcriptome analysis (Table 2.3).
Further, growth phenotype results (Table 2.4) showed that the lysP mutant grew very poorly on
L-Lys suggesting the importance of lysP for L-Lys uptake in PAO1. Previous studies showed
that lysP is induced by L-Arg and ArgR is a repressor for lysP. Promoter activity assay was
conducted in vitro using pLYSP in wild-typw PAO1 and various mutants. It was found that lysP
was induced by L-Arg and L-Lys and the promoter activity was increased by several folds in
PAO501 (Figure 2.10) confirming that ArgR is indeed a transcriptional repressor of lysP. The
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expression of lysP was not affected in PW8366 indicating that LysR is not a transcriptional
regulator of this gene. Further, it was observed that lysP activation was completely lost in aruS
and aruR mutants. The aruSR two component system was shown to be induced by L-Arg. The
uptake system lysP being under the control of two arginine regulatory systems explains for the
poor growth of PAO1 on L-Lys suggesting that the uptake is one bottleneck in L-Lys utilization.

Figure 2.10 Expression of lysP promoter in vivo.
The promoter activity of lysP was monitored by measuring β-galactosidase activity in the wildtype & mutant PAO1 harboring the pLysP plasmid. The cells were grown in glutamate minimal
medium in presence of various compounds as indicated above (10 mM). Specific activity values
represent the mean ± standard deviation of three measurements for each growth condition. L-Glu,
L-glutamate; L-Lys, L-lysine; L-Arg, L-arginine; D-Lys, D-lysine.
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2.4

Discussion
2.4.1

Glutarate catabolism plays a pivotal role in lysine catabolism.

L-Lys catabolism in P. aeruginosa is mainly mediated by the lysine decarboxylase pathway, which
converts L-Lys into glutarate. Previous reports from our group have characterized all genes
encoding enzymes in this process. In the current study, the gcdHG operon was identified to play
essential roles in glutarate catabolism from the results of transcriptome analysis (Table 2.3) and
growth phenotype analysis (Table 2.4). Genome annotations predicted GcdH as glutaryl-CoA
dehydrogenase and GcdG as putative acyl-CoA transferase (www.pseudomonas.com). In
conjunction with our results presented here, this information supported GcdG and GcdH as
glutaryl-CoA transferase and glutaryl-CoA dehydrogenase that catalyze two contiguous reactions
to convert glutarate into crotonyl-CoA (42, 46).

Not only essential for L-Lys catabolism, it was found in our study that the gcdG and gcdH mutants
cannot grow on L-Pip, suggesting that L-Pip is also degraded via glutarate. L-Pip is an intermediate
compound of D-Lys catabolism (Figure 1.1), followed by the generation of 2-aminoadipate.
Enzymes and their coding genes that are involved in the conversion of L-Pip to 2-aminoadipate
have been identified in P. putida (34) and P. aeruginosa PAO1 in this study. However, information
regarding degradation of 2-aminoadipate to glutarate was still missing. One possible player in this
process might be PA2035 encoding a TPP-dependent decarboxylase. The PA2035 gene found
inducible by D-Lys and L-Pip in transcriptome analyses (Table 2.3), and the knockout mutant of
PA2035 completely lost the ability to grow on L-Pip (Table 2.4) suggesting that PA2035 is
essential for L-Pip utilization in PAO1.
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2.4.2

The GcdR transcriptional activator responds to its signaling compound
glutarate.

Several lines of evidence support the conclusion that GcdR is the transcriptional activator for the
gcdH promoter. First, the gcdR mutant cannot grow on L-Lys or its catabolic intermediates Cad,
AMV or GA. Second, induction of the gcdH promoter by exogenous GA was completely abolished
in the gcdR mutant. Third, the purified recombinant GcdR protein binds to the regulatory region
of the gcdH promoter. A combination of serial deletion analysis and multiple sequence alignments
led us to identify a highly conserved sequence motif among species of Pseudomonas as the GcdR
operator site in the gcdH promoter region (Figure 2.3).

2.4.3

Lysine uptake and export are two bottlenecks for growth on L-Lys.

P. aeruginosa PAO1 can utilize L-Lys as the sole source of carbon and nitrogen. However, it has
been observed that under this growth condition with L-Lys, the wild-type strain PAO1 spent a very
long lag phase before resuming logarithmic growth. We have reported that the lysine
decarboxylase LdcA was subjected to induction by L-arginine and the ArgR transcriptional
regulator (5), and hence considered the lack of lysine-dependent induction of ldcA as the bottleneck
for L-Lys catabolism.

In the current study, we found that the presence of a lysine-inducible exporter posed another major
limiting factor for growth on L-Lys. From the transcriptome analysis, the lysXE genes were found
to be induced specifically by exogenous L-Lys and this was confirmed by promoter activity
measurements. The lysXE genes encode an uncharacterized protein with one Pfam ATC3 domain
and a putative lysine efflux protein, respectively, while the divergent lysR gene encodes a
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transcriptional regulator. The lysE gene shares 45 % sequence similarity with the arginine exporter
ArgO of E. coli. Knockout mutants of lysR, lysX, and lysE were found to grow much better than
the wild-type PAO1 on MMP agar with L-Lys as the sole source of carbon and nitrogen. In liquid
media, the lysR, lysX and lysE mutants had a much shorter lag-phase compared with the wild-type
PAO1. Also, the estimated generation time of these mutants was shorter (9-13 h) than that of the
WT (19 h). We believe that the shorter lag phase and generation time observed in lysR, lysX, and
lysE mutants was due to the lack of a functional lysine exporter, resulting in higher intracellular
concentrations of L-Lys compared with the wild-type PAO1.

Previous studies from our lab showed that the AotJQMP transporter for L-Arg uptake is also
induced by L-Lys. The first enzyme in L-Lys catabolism is under the control of ArgR, an arginine
responsive regulator, and L-Arg. These two things lead to the belief that L-Lys uptake is also
mediated by the AotJQMP transporter. However, growth phenotype results in this study showed
that the lysP mutant almost lost the ability to grow on L-Lys as the sole carbon and nitrogen source
indicating its importance in L-Lys uptake. Further, we found that lysP promoter was induced by
both L-Arg and L-Lys. This induction effect by L-Arg was enhanced several folds in the argR
mutant confirming its repression effect on lysP transcription. In addition, we found that the
induction of lysP was completely abolished in the aruS and aruR mutants which are again known
to respond to exogenous L-Arg. This suggests that the uptake via an L-Arg responsive and ArgR
regulated transporter also is another reason for the poor growth of PAO1 on Lysine.
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2.4.4

The LysR transcriptional activator responds to its signaling compound LLys.

Several lines of evidence support the conclusion that LysR is the transcriptional activator for the
lysX promoter. First, the lysR mutants grow much better than the wild-type PAO1 (possibly due to
the absence of LysX and LysE). Second, the induction of the lysX promoter by exogenous L-Lys
was completely abolished in the lysR mutant. Third, the purified recombinant LysR protein binds
to the regulatory region of the lysX promoter. The LysR operator site in the lysX promoter region
was also deduced from the results of serial deletions and multiple sequence alignments (Figures
2.4 & 2.6)

2.4.5

Interconnected regulatory systems for ArgR and Lysine metabolism.

Findings from the current study and previous reports indicated the presence of a sophisticated
regulatory network of Arg and Lys uptake and catabolism in Pseudomonas. As shown in Figure
2.11, there are at least four transcriptional regulators that respond to Arg and Lys – LysR (L-Lys),
AruSR (L-Lys and L-Arg), ArgR (L-Arg) and DauR (D-Lys and D-Arg). P. aeruginosa is well
equipped to grow more efficiently on Arg than on Lys, with the ArgR regulator in response to LArg as the major player to control the entire arginine network (33, 36), including the AotJQMP
transporter for L-Arg and L-Lys uptake. Furthermore, the ArgR extended its influence to Lys
catabolism through its control on ldcA for L-Lys decarboxylase (5), dauBAR-dauT for D-Lys/DArg dehydrogenase and uptake, and potentially on lysP and aruH for L-Lys uptake and L-Lys/LArg aminotransferase (65). The overall efficiency of L-Lys catabolism was further dampened by
the presence of L-Lys exporter LysXE that is subjected to positive regulation by the LysR regulator
in response to L-Lys as depicted in this study. The physiological significance of this observed
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nutritional preference for Arg over Lys in Pseudomonas was a very intriguing question for future
investigation.

Figure 2.11 Schematic summary of arginine and lysine interconnected regulatory networks.
The transcriptional regulators along with their signal compounds and the genes under their
control are connected with either an arrow for positive effect ‘┬’ or for negative effect.

In conclusion, we have characterized several new members of the L-Lys and D-Lys catabolic
pathways and their regulatory elements, including gcdR-gcdHG for glutarate utilization, dpkA,
amaR-amaAB and PA2035 for D-Lys catabolism, lysR-lysXE for putative L-Lys efflux, lysP
(PA4981) for putative L-Lys uptake. Integration of these new data with information from previous
reports led us to discover an inducible amino acid exporter as a bottleneck for L-Lys catabolism
and to decipher a tightly interconnected metabolic network for D-Lys and L-Lys in Pseudomonas.
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3

CHARACTERIZATION OF ANABOLIC L-ARGININE DEHYDROGENASE DAUB
OF PSEUDOMONAS AERUGINOSA PAO1

3.1

Introduction

Proteins are composed of L-amino acids predominantly. However, the D-amino acids are also part
of living organisms and are important for various cellular functions. D-amino acids are essential
components of bacterial cell walls (53). D-serine and D-aspartate were shown to be involved in
cellular aging and neural signaling, respectively (41, 42). Amino acid racemases catalyze the
conversion of L-forms of the amino acids into the D-forms for these purposes. Some D-amino
acids can be used for growth by bacteria when in excess with the help of these racemases. P.
aeruginosa PAO1 has been shown to possess coupled dehydrogenases DauA and DauB that
facilitate the racemization of D-arginine (D-Arg) to L-arginine (L-Arg) (31). The dauA gene
encodes for the enzyme catabolic D-arginine dehydrogenase while dauB gene encodes for the
enzyme anabolic L-arginine dehydrogenase. The proposed biochemical reaction of these coupled
enzymes is as follows:

Figure 3.1 Schematic representation of arginine racemization.
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DauA can utilize a number of D-amino acids as the substrate in addition to D-Arg to generate
their respective keto-acid and ammonia (33) as shown in Figure 3.2

Figure 3.2 Substrate specificity of DauA.
The substrate specificity of DauA as determined from the D-amino acid dehydrogenase activity
of the purified enzyme. The enzyme activity towards D-Arg was taken as 100 %, and with
respect to it, the relative activity towards each D-amino acid was calculated. This figure is
adapted from Li et al, 2010 (33).

DauB is a bidirectional enzyme that can use either 2-ketoarginine + NH4Cl in a forward reaction
or L-Arg in a reverse reaction with NADH/NADPH or NAD+/NADP+ as the cofactors
respectively. In this research, we attempted to characterize the enzyme DauB. I hypothesized
that, if DauA and DauB are coupled enzymes, then DauB should also be able to utilize other Damino acids as a substrate like it partner enzyme DauA. We also attempted to characterize the
DauB enzyme kinetics.
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3.2

Materials and methods

3.2.1

Bacterial strains, plasmids and growth conditions.

P. aeruginosa PAO1 wild-type (8), E. coli DH5α (Bethesda Research Laboratories) and Top10
(Invitrogen) were used in this study. Both E. coli and P. aeruginosa were routinely grown and
maintained in Luria–Bertani (LB) medium. Ampicillin at 100 µg/ml was supplemented in the
growth medium when required for E. coli. The protein expression vector pBAD-HisE (32) was
used in this study to clone and express recombinant DauB protein.

3.2.2

Cloning, expression and purification of hexahistidine tagged DauB.

The dauB gene excluding the translational stop codon was amplified from the genomic DNA of P.
aeruginosa

PAO1

wild

type

CGCTCATGAGCGCCGCCACTCCC-3’

using

the
and

primers

DauB-HisCF:

DauB-HisCR:

5’5’-

TCCCCCGGGGCCTGCCTGGCGCAGGCG-3’. The resulting PCR fragments were digested
with BspHI/SmaI restriction enzymes and cloned into pBAD HisE plasmid vector (31) so that the
C-terminus of DauB was fused in-frame with the His6-tag while the N-terminus is preceded by a
ribosome binding site and an arabinose-inducible promoter in the plasmid. pDAUB was introduced
into E. coli Top10 (Invitrogen). For overexpression of DauB-HisC, the recombinant strains of E.
coli were grown in LB medium containing ampicillin at 37°C. For over expression, 0.2 % Larabinose (w/v) was added to the culture when the OD600 was approximately 0.5-0.6. After 4 h of
vigorous shaking at 37 °C, cells were harvested by centrifugation and stored at -80 °C until use.
The cell pellets were suspended in phosphate buffer A (20 mM Na2HPO4, 0.5 M NaCl, 20 mM
imidazole, pH 7.5) with PMSF (1 mM) as a protease inhibitor and the cells were ruptured by an
Aminco French press. Cell debris was removed by centrifugation at 30,000 g for 30 min. The
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supernatant was applied to a HisTrap HP column (GE Health Care) and the His-tagged DauB was
eluted at 20-60 % buffer B (20 mM Na2HPO4, 0.5 M NaCl, 1 M imidazole, pH 7.5). The target
fractions were analyzed by SDS-PAGE, pooled and concentrated using an Amicon Ultra-15
centrifugal filter unit (molecular mass cut-off, 30 kDa; Millipore) to change the buffer to 20 mM
Tris-HCl (pH 7.5). Protein concentration was determined by the method of Bradford (27).

3.2.3

DauB enzyme assay.

DauB enzyme activity was measured using the reverse reaction as described earlier (31, 33). LArg was used as the substrate and the formation of NADH was measured at 340 nm using Cary
3E (Varian). The reaction mixture contained L-Arg, NAD+, and purified DauB in 50 mM TrisHCl in a total volume of 2 ml. The reaction mix lacking L-arginine, NAD+ or DauB-HisC was preincubated at 37 °C. The reaction was initiated by adding the missing component and followed for
up to 15 min.

3.3

Results

3.3.1

DauB pH profile.

Little to no enzyme activity, as determined by the formation of NADH, was detected at near
neutral pH. As the pH increased, the enzyme activity increased and peaked at pH 9.0 and then
started to reduce (Figure 3.3). Hence, pH 9.0 was taken as the optimal pH for the DauB
enzymatic reaction and was used for all subsequent assays.
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Figure 3.3 DauB pH profile.
Each reaction included 141 µg of purified DauB-HisC, 10 mM L-Arg, 0.5 mM NAD+, 50mM TrisHCl (pH 7, 7.5, 8, 8.5, 9, 9.5 and 10) in 2 ml. The reaction was followed for 5 min after adding the
amino acid at 37°C to the pre-incubated reaction mixture.

3.3.2

DauB enzyme activity with varied enzyme concentrations.

In order to find the optimal enzyme concentration under the given experimental conditions, DauB
enzyme activity was measured with fixed concentrations of L-Arg (10 mM), NAD+ (0.5 mM) and
varied enzyme concentration. The reaction was initiated by the addition of the enzyme to the prewarmed reaction mix and the reaction was followed for 5 min by measuring the formation of
NADH. It was found that 70.5 µg of DauB-HisC gives a reaction velocity in the linear range
(Figure 3.4). Hence this concentration was used for further analyses.
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Figure 3.4 DauB enzyme activity with varied enzyme concentrations.
Each reaction included DauB-HisC (23.7, 47, 70.5, 94, 117.5, 141, 164.5, 188, 211.5 and 235 µg),
10 mM L-Arg, 0.5 mM NAD+ and 50 mM Tris-HCl pH 9 in 2 ml. The reaction was followed for
5 min at 37 °C after adding enzyme to the pre-incubated reaction mix.

3.3.3

DauB enzyme activity with varied L-arginine concentrations.

This experiment was conducted to find the kinetic parameters for L-Arg used in the reaction. The
reaction was initiated by the addition of the enzyme to pre-incubated reaction mix and was
followed for 5 min. It was found that the Km was 15.45 mM of L-Arg and the Vmax for DauB
under these reaction conditions was 1.03 µM/S (Figure 3.5).
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Figure 3.5 DauB enzyme activity with varied L-arginine concentrations.
Each reaction included L-Arg (1, 2, 2.5, 5, 7.5, 10, 12.5, 15, 17.5, and 20 mM), 70.5 µg of DauBHisC, 0.5 mM NAD+, 50 mM Tris-HCl pH 9 in 2 ml. Each reaction was followed for 5 min after
the addition of enzyme to the pre-incubated reaction mix.

3.3.4

DauB enzyme activity with varied NAD+ concentrations.

This experiment was conducted to find the kinetic parameters for NAD+ used in the reaction. The
reaction was initiated by the addition of the enzyme to pre-incubated reaction mix and was
followed for 5 min. The concentration of L-Arg used in this reaction was increased to 40 mM
from 10 mM based on the calculated Km for L-Arg It was found that the Km was 1.88 mM of
NAD+ and the Vmax for DauB under these reaction conditions was 0.80 µM/S (Figure 3.6).
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Figure 3.6 DauB enzyme activity with varied NAD+ concentrations.
Each reaction included NAD+ (0.5, 1, 2, 3, 4, 5, 10, 15 and 20 mM), 70.5 µg of DauB-HisC, 40
mM L-Arg, 50 mM Tris-HCl pH 9 in 2 ml. Each reaction was followed for 5 min after the addition
of enzyme to the pre-incubated reaction mix.

3.3.5

Substrate specificity of DauB.

DauA was shown to utilize a number of D-amino acids very well as its substrate. Since DauBA
are coupled dehydrogenases, we set to determine if DauB will complement the substrate specificity
shown by DauA. Each reaction was initiated by the addition of the addition of DauB to preincubated reaction mix and was followed for 15 min. It was found that unlike its partner enzyme
DauA, DauB can utilize only L-Arg as a good substrate (Figure 3.7). Hence, DauB is an argininespecific dehydrogenase enzyme.
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Figure 3.7 In vitro substrate specificity of DauB enzyme.
Each reaction included 70.5 µg of DauB-HisC, 0.5 mM NAD+, 10 mM L-amino acid, 50 mM TrisHCl pH 9.0 in 2 ml. The reaction was followed for 15 min after adding DauB at 37 °C to the preincubated reaction mixture.

3.4

Discussion
3.4.1

DauB is an arginine-specific dehydrogenase.

In order to identify the optimal reaction conditions and kinetic parameters, we used purified Cterminal hexahistidine tagged DauB enzyme. As shown in Figure 2.3, at pH 9.0, DauB exhibited
maximal enzyme activity under our experimental conditions. The Km value for L-Arg was 15.45
mM using 70.5 µg of DauB and 0.5 mM of NAD+ and the Vmax for DauB under these reaction
conditions was 1.03 µM/S (Figure 2.5). The Km of NAD+ was 1.88 mM 70.5 µg of DauB and
40mM L-Arg and the Vmax for DauB under these reaction conditions was 0.8µM/S (Figure 3.6).
DauB showed relatively little to no activity using other L-amino acids as substrates (shown in
Figure 3.7) as compared to that against L-Arg (taken as 100%). This indicates that DauB is an
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arginine-specific dehydrogenase unlike its partner, DauA dehydrogenase, which can utilize a
number of D-amino acids as the substrate (Figure 3.2). In addition, it is very likely that the
potential DauAB complex is either formed in presence of D-Arg only or is limited to the
racemization of D-Arg to L-Arg considering that these two enzymes vary widely in their
substrate specificity.

Transcription of the dauBAR operon is induced by D-Arg and D-Lys and this is further enhanced
by L-Arg in the presence of ArgR (33). Even though DauA was shown to utilize a number of Damino acids as its substrates in vitro, only utilization of D-Arg as carbon and or nitrogen source
was abolished in the dauA mutant (33). In the case of DauB, in agreement with the in vitro
enzymatic assays in the current study and the previous studies (31), the dauB mutant can utilize
D-Arg as a nitrogen source but not as carbon. All these support the unique role of DauBA in DArg catabolism.
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4

IN VIVO SUBSTRATE SPECIFICITY OF D-AMINO ACID DEHYDROGENASES
IN PSEUDOMONAS AERUGINOSA PAO1

4.1

Introduction

D-amino acids are formed by racemization from cognate L-enantiomers. Until recent times the
physiological importance of D-amino acids was not well known other than the presence of D-Ala
and D-Glu in bacterial cell wall. However, recent studies revealed that the D-amino acids play
many other important functions. Gramicidin is an antimicrobial peptide produced by Bacillus
brevis that contains D-amino acids (4). DadA, D-alanine dehydrogenase, is involved in multiple
virulence factor production in P. aeruginosa (43). In addition, many groups have demonstrated
that D-amino acids can be detrimental to the cell. D-amino acids in combination with β-lactam
antibiotics were shown to alter cell morphology (1). Bacillus subtilis was shown to produce a
mixture of D-Leu, D-Met, D-Tyr and D-Trp that prevented biofilm formation and also disassemble
existing biofilms (26). Lam et al., (28) found unusual D-amino acids in Vibrio cholerae and
Bacillus subtilis that seemed to modify the cell wall in stationary phase cultures. D-amino acids
given in combination with antimicrobials has a synergistic effect on biofilm dispersal in some
isolates of P. aeruginosa and Staphylococcus aureus (52)

P. aeruginosa PAO1 has three known D-amino acid dehydrogenases. D-Arginine dehydrogenase
encoded by the gene dauA is part of a two-component racemase that converts D-arginine to Larginine (31, 33). This gene is indispensable for the utilization of D-Arg in PAO1. It was shown
to utilize a number of D-amino acids as the substrate in vitro. D-Alanine dehydrogenase encoded
by dadA gene is involved in the conversion of D-Ala to pyruvate and ammonia and was also shown
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to utilize many D-amino acids as its substrate. DadA is essential for the utilization of D-Ala, DVal, D-Ser, D-Thr, D-Phe and D-His in PAO1. Although the dadA promoter is induced by several
L-amino acids and by D-Ala, L-Ala was proposed as the signaling molecule for its transcriptional
regulator DadR (19). D-Glutamate dehydrogenase encoded by the gene dguA is involved in the
deamination of D-Glu and D-Gln (20). These three gens are essential for the utilization of the
above mentioned D-amino acids as carbon and nitrogen sources. Since, the natural occurrence of
D-amino acids is much less compared to the L-forms, we hypothesized that there could be a much
important role for these dehydrogenases other than aiding the cell utilize these D-amino acids as
nutrient sources. We hypothesized that the lack of the dauA, dadA, and dguA genes might weaken
the cell and make it more susceptible to antibiotics when given in combination with D-amino acids.

4.2

Materials and methods

4.2.1

Strains and growth conditions.

Bacterial strains used in this study were listed in Table 3.1. Luria–Bertani (LB) medium was used
for bacterial growth with the following supplements as required: ampicillin at 100 µg/ml,
carbenicillin at 100 µg/ml for E. coli, and streptomycin at 500 µg/ml and gentamicin at 30 µg/ml
for P. aeruginosa. Minimal medium P (MMP) supplemented with specific carbon sources and
nitrogen sources was used for the growth of P. aeruginosa (17).
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Table 4.1 Bacterial strains and plasmids used in this study.
Strain or plasmid
E. coli
DH5α

TOP10

SM10
P. aeruginosa
PAO1
PAO1-Smr
PAO5731
PAO5434
Plasmids
pRTP2
pPS856
pFLP2
pUCP18
pRTP2
ΔdauA::Gm
pRTP2
ΔdadA::Gm
pUCP18DguA
pUCP18DauA
pUCP18DauBA
pUCP18DadA
Smr, streptomycin
sucrose-sensitive
4.2.2

Genotype or description

Source

F– Φ80lacZΔM15 Δ(lacZYA-argF)
U169 recA1 endA1 hsdR17 (rK–, mK+) phoA
supE44 λ– thi1 gyrA96 relA1
F– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15
ΔlacX74 recA1araD139 Δ(ara leu) 7697 galU
galK rpsL
(StrR) endA1 nupG
thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu
(Kmr)

Bethesda
Research
Laboratories

Wild type
Spontaneous Smr mutant strain of PAO1
ΔdguA
ΔdguA; ΔdadA; ΔdauA

(18)
(23)
(20)
This study

Invitrogen

(56)

Ampr Sms conjugation vector derived from pRTP1
(31)
r
r
Amp , Gm cloning vector
(22)
Ampr, sacB+ containing broad host range cloning
(22)
vector
Escherichia-Pseudomonas shuttle vector
(55)
pRTP2 with upstream and downstream of dauA
This study
linked by Gm cassette from pPS856
pRTP2 with upstream and downstream of dadA
This study
linked by Gm cassette from pPS856
pCUP18 derivative carrying the dguA gene
This study
pCUP18 derivative carrying the dauA gene
Congran Li (CR5.1)
pCUP18 derivative carrying the dauBA genes
This study
pCUP18 derivative carrying the dadA gene
This study
resistance; Ampr, ampicillin resistance; Gm, gentamicin resistance; sacB+,

Construction of D-amino acid dehydrogenase triple mutant.

A ΔdguA, ΔdadA, and ΔdauA triple mutant of PAO1 devoid of the three D-amino acid
dehydrogenases, was constructed using a markerless gene deletion technique described
previously (22). PAO5731 (ΔdguA), a derivative of PAO1 was used as the host to construct this
triple dehydrogenase mutant. Briefly, the flanking regions of the dauA or dadA were amplified
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by PCR, and restriction enzymes sites were introduced into the primers so that the PCR products
possess configurations of 5′-BamHI-[left arm]-SmaI-3′ and 5′-SmaI-[right arm]- HindIII-3′. A
1.6-kb EcoRI fragment containing the gentamicin resistance (Gmr) cassette was excised from the
plasmid pPS856 by digesting with SmaI. After restriction enzyme digestion, these three DNA
fragments were ligated and cloned into the BamHI and HindIII sites of pRTP2. The final plasmid
construct was introduced into E. coli SM10 to serve as the donor in the biparental conjugation,
with PAO1-Smr as the recipient. After incubation at 37 °C for 6 h, the transconjugants were
spread and selected on LB plates supplemented with streptomycin and gentamicin. The protocol
for gene replacement and in vivo excision by the Flp-FRT recombination system was used to
remove the gentamicin resistance marker facilitating the generation of unmarked mutants of
PAO1 with deletions on multiple genes. Expected deletions in these mutants were confirmed by
PCR and by growth in specific D-amino acids that require these genes for catabolism.

4.2.3

Construction and verification of D-amino acid dehydrogenase
complementation clones.

The dguA, dadA, dauA or dauBA genes were amplified from the genomic DNA of PAO1 along
with their ribosome binding site (RBS) and were cloned into pUCP18 plasmid vector. The
recombinant plasmids were verified by DNA sequencing and introduced into the ΔdguA, ΔdadA,
and ΔdauA triple mutant independently. Two single colonies of the triple mutant with or without
the gene complementation clone were resuspended in phosphate buffered saline and inoculated
into MMP broth supplemented 20 mM L-Glu/10 mM D-Glucose + 10 mM D-Glu, D-Arg or DAla/20 mM D-Glu, D-Arg or D-Ala for carbon and or nitrogen sources. Growth was followed
by visual inspection for turbidity at 37 °C, 300 rpm for up to 3 days.
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4.2.4

Determination of MIC for wild-type PAO1 and the ΔdguA, ΔdadA, and
ΔdauA triple mutant.

Minimal inhibition concentrations (MICs) of antibiotics was determined by a liquid
microdilution method according to the guidelines of the Clinical and Laboratory Standards
Institute (8). Serial two-fold dilutions of the antibiotics in LB broth were prepared in a 96-well
microtiter plate. LB broth without any antibiotic was used for both positive (inoculated) and
negative (uninoculated) controls. Fresh overnight cultures of wild-type PAO1 and the ΔdguA,
ΔdadA, and ΔdauA triple mutant (two independent cultures each) were diluted and inoculated
with approximate 5 x 104 CFU/well. Cells were incubated without shaking at 37 ºC for 24 h. The
lowest concentration of antimicrobial agent at which cells were not able to grow was defined as
its MIC.

4.2.5

In vivo substrate specificity of D-amino acid dehydrogenases.

MMP broth supplemented with various D-amino acids as C and N source (20 mM) or as N
source (5 mM) were prepared. When testing for nitrogen utilization, 10 mM D-Glucose was
supplemented as a carbon source. The pH of the final medium was neutralized using HCl or
NaOH. About 5 x 104 CFU of wild-type PAO1 and the ΔdguA, ΔdadA, and ΔdauA triple mutant
with or without the gene complementation clones (two independent cultures for each genotype
tested) were inoculated. MMP medium with 10 mM D-Glucose and 0.5 % NH4Cl was used as
positive (inoculated) and negative (un-inoculated) controls. The plates were incubated at 37 °C
and growth was noted by visual inspection 2 and 4 days post-inoculation.
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4.2.6

Effect of D-amino acids given in conjunction with antibiotics.

LB medium was supplemented with 5 mM of various D-amino acids in combination with 1X,
0.5X or 0.25X MIC of carbenicillin, gentamicin or tetracycline. About 5 x 104 CFU of wild-type
PAO1 or the ΔdguA, ΔdadA, and ΔdauA triple mutant were inoculated into each well. The plates
were incubated at 37 °C and growth was recorded by measuring OD600 24 h post-inoculation. LB
medium without any antibiotic or D-amino acid was used as positive control while the same
without any bacterial cells served as negative control.

4.3

Results
4.3.1

Verification of ΔdguA, ΔdadA, and ΔdauA triple mutant.

The triple mutant was tested for the loss of dauA, dadA, and dguA genes by PCR. The loss of
these three genes was confirmed by testing the ability of the wild-type PAO1 and the triple
mutant to utilize D-Glu, D-Arg and D-Ala as sole carbon and or nitrogen sources in minimal
medium P. The wild-type PAO1 was able to utilize all the three D-amino acids tested as both
carbon and nitrogen sources. The triple mutant could not use any of these compounds as either
carbon or nitrogen sources indicating the loss of dauA, dadA, and dguA genes as expected. The
gene organization of the three dehydrogenase genes in wild-type PAO1 and the ΔdguA, ΔdauA,
and ΔdadA triple mutant along with the gene complementation clones is shown in Figure 4.1
below.
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Figure 4.1 Dehydrogenase gene organization and gene complementation.
(a) Organization of the three dehydrogenase genes in wild-type PAO1. The dashed outline

indicates the genomic region deleted in each locus to construct the ΔdguA, ΔdauA, and ΔdadA
triple mutant. (b) Gene complementation clones constructed in the pUCP18 plasmid to
complement each dehydrogenase gene in the ΔdguA, ΔdauA, and ΔdadA triple mutant.

4.3.2

D-amino acid dehydrogenase gene complementation.

In order to test for the in vivo substrate specificity of the D-amino acid dehydrogenases, gene
complementation clones were constructed using the pUCP18 plasmid, an E. coli-Pseduomonas
shuttle vector. Each D-amino acid dehydrogenase was cloned along with its ribosome binding
site such that the gene expression is driven by the lacZ promoter on the pCUP18 plasmid (see
Figure 4.1). These plasmids can reach 10 to 25 copies per cell with constitutive expression in P.
aeruginosa (14). During the testing of gene complementation, we observed that the
complementation of dauA gene could only restore utilization of D-Arg as a nitrogen source. This
could be due to a non-functional dauB gene or DauB protein which may have got disrupted in
part during the deletion of dauA. Hence, the dauBA complementation clone was also included in
the analysis. It was found that the dguA, dadA, dauA, and dauBA gene clones all were able to

64

support growth on D-Glu, D-Ala, and D-Arg, as anticipated indicating that the gene
complementation worked.
4.3.3

Antibiotic susceptibility of wild-type PAO1 and the ΔdguA, ΔdauA, and
ΔdadA triple mutant.

The susceptibility of wild-type PAO1 and the ΔdguA, ΔdauA, and ΔdadA triple mutant were
tested for the antibiotic commonly used in the laboratory. It was found that the ΔdguA, ΔdauA,
and ΔdadA triple mutant had two-fold lower minimum inhibition concentration (MIC) for
carbenicillin and tetracycline while gentamicin remained same as compared to the wild-type
PAO1 (see Table 4.2). This supports our hypothesis that the triple mutant is weakened though by
unknown mechanism(s).
Table 4.2 MIC for wild-type PAO1 and the ΔdguA, ΔdauA, and ΔdadA triple mutant.

WT PAO1
PAO5434
4.3.4

Minimum inhibitory concentration (MIC) (µg/mL)
Carbenicillin
Gentamicin
Tetracycline
64
8
16
32
8
8

In vivo substrate specificity of D-amino acid dehydrogenases.

Previous studies used purified His-tagged proteins and tested the substrate specificity of D-amino
acid dehydrogenases in vitro. Each D-amino acid dehydrogenase was shown to utilize more than
one D-amino acid as the substrate. Hence, the mutant growth phenotypes may or may not be an
accurate reflection of the in vivo characteristics of these enzymes. Here, we tried to see the in
vivo substrate specificity of the D-amino acid dehydrogenases. It was found that DadA can
utilize D-Ala, D-Val, D-His, D-Lys, D-Arg, D-Ser, D-Pro, D-Met, and D-Phe as the substrates.
DguA can utilize D-Glu, D-Gln, and D-Ser as substrates. DauA can utilize D-His, D-Orn, D-Lys,
D-Arg, D-Pro, D-Met, and D-Phe as substrates (see Table 4.3).
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Table 4.3 In vivo substrate specificity of D-amino acid dehydrogenases.
PAO5434 (ΔdguA, ΔdauA, and ΔdadA) + gene complement

Wild-type
PAO1

None

dguA

dadA

dauA

dauBA

N

CN

N

CN

N

CN

N

CN

N

CN

N

CN

D-Ala

+

+

-

-

-

-

+

+

-

-

-

-

D-Val

+

+

-

-

-

-

+

+

-

-

-

-

D-Glu

+

+

-

-

+

+

-

-

-

-

-

D-Gln

+

+

+

+

++

++

+

+

+

+

+

+

D-His

+

-

+

-

+

-

++

-

++

-

++

-

D-Asn

+

-

+

-

+

-

+

-

+

-

+

-

D-Asp

-

-

-

-

-

-

-

-

-

-

-

-

D-Orn

+

-

-

-

-

-

-

-

+

-

+

-

D-Lys

+

-

-

-

-

-

+

-

++

-

++

-

D-Arg

+

+

-

-

-

-

+

-

++

-

++

++

D-Ser

+

-

+

-

++

-

++

+

+

-

+

-

D-Thr

+

-

+

-

+

-

+

-

+

-

+

-

D-Pro

+

-

-

-

-

-

+

-

+

-

+

-

D-Met

+

-

+

-

+

-

++

-

++

-

++

-

D-Phe

+

-

+

-

+

-

+

+

+

+

+

+

The data represents at least two independent sets of culture under each condition tested. Inoculated
and un-inoculated LB medium was used as the positive and negative controls (not shown in table).
Results were observed 2 days and 4 days post inoculation. Growth is by + and – is no growth even
after 4 days. The ++ sign indicates that these cells grew better than or on par with the wild-type by
2 days itself indicating that the complemented gene enhances growth on that substrate. Grey
colored cells indicate that the enzyme encoded by complemented gene can utilize that D-amino
acid as a substrate.
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4.3.5

Effect of D-amino acids given in conjunction with antibiotics.

Based on previous reports from various groups it was expected that D-amino acids might weaken
the cell wall making it more permeable to antibiotics. Alternatively. the lack of the dguA, dadA,
and dauA genes may also make the cell more resistant as a coping mechanism. When the cells
were exposed to 1X MIC of carbenicillin, presence of D-Phe and D-Pro resulted in cell growth
both in the wild-type PAO1 and the ΔdguA, ΔdauA and ΔdadA triple mutant. At lower
concentrations of carbenicillin (0.5X and 0.25X MIC), both the wild-type and the triple mutant
cells grew normally like the respective control groups. When the cells were exposed to
gentamicin, growth was completely abolished at 1X MIC. Further, even at 0.5X MIC the
presence of any D-amino acid tested resulted in complete growth inhibition both in the wild-type
and the ΔdguA, ΔdauA, and ΔdadA triple mutant cells indicating synergy between gentamicin
and D-amino acids. When the cells were exposed to tetracycline, growth was completely
abolished at 1X MIC. Further both at 0.5X and 0.25X MIC, a significant growth reduction was
noted both in the wild-type and the ΔdguA, ΔdauA, and ΔdadA triple mutant cells as compared to
the respective control groups indicating synergy between tetracycline and the D-amino acids
tested. However, no special synergistic or antagonistic effects were observed specifically in the
ΔdguA, ΔdauA, and ΔdadA triple mutant as compared to the wild-type PAO1 when D-amino
acids were given in combination with antibiotics (see Tables 4.4 and 4.5).
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Table 4.4 Effect of D-amino acids given in conjunction with antibiotics in wild-type PAOI.
MIC

Antibiotic

Carbenicillin
(µg/mL)
1X
64
0.5X
32
0.25X
16
Carbenicillin
(µg/mL)
1X
64
0.5X
32
0.25X
16

1X
0.5X
0.25X

1X
0.5X
0.25X

Gentamicin
(µg/mL)
8
4
2
Gentamicin
(µg/mL)
8
4
2

Wild-type PAO1
Ala
0.00
0.34
0.24

Val
0.00
0.29
0.23

Glu
0.00
0.38
0.28

Gln
0.00
0.41
0.40

His
0.00
0.88
0.28

Asn
0.00
0.46
0.27

Asp
0.00
0.37
0.21

Orn
0.00
0.44
0.24

Lys
0.00
0.73
0.23

Arg
0.00
0.82
0.32

Ser
0.07
0.18
0.27

Thr
0.02
0.25
0.18

Pro
0.91
0.33
0.25

Phe
0.32
0.27
0.25

Ala
0.00
0.00
0.62

Val
0.00
0.00
0.41

Glu
0.00
0.00
0.47

Gln
0.00
0.00
0.53

His
0.00
0.00
0.61

Asn
0.00
0.00
0.62

Asp
0.00
0.00
0.70

Orn
0.00
0.00
0.57

Lys
0.00
0.00
0.68

Arg
0.00
0.00
0.43

Ser
0.00
0.00
0.40

Thr
0.00
0.00
0.51

Pro
0.00
0.00
0.66

Phe
0.00
0.00
0.45

Positive
control
0.62
0.55
0.53
Positive
control
0.46
0.57
0.50
Positive
control
0.68
0.66
0.80
Positive
control
0.73
0.65
0.89

Tetracycline
Positive
(µg/mL)
Ala
Val
Glu
Gln
His
Asn
Asp
control
1X
16
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.83
0.5X
8
0.15
0.34
0.43
0.38
0.21
0.01
0.00
0.75
0.25X
4
0.42
0.38
0.57
0.47
0.45
0.33
0.22
0.85
Tetracycline
Positive
(µg/mL)
Orn
Lys
Arg
Ser
Thr
Pro
Phe
control
1X
16
0.00
-0.01
0.00
0.00
0.00
0.00
-0.01
0.89
0.5X
8
0.40
0.13
0.10
0.19
0.00
0.25
0.12
0.75
0.25X
4
0.61
0.34
0.33
0.32
0.47
0.50
0.38
1.10
About 5 x 104 cells of WT PAO1 were inoculated into LB broth supplemented with 5 mM of
various D-Amino acids in combination with 1X, 0.5X or 0.25X MIC of carbenicillin, gentamicin
or tetracycline. The 96-well plates were incubated at 37 °C and growth was recorded by
measuring OD600 24 h post inoculation. These results are an average of two independent sets of
culture under each condition. LB medium without any antibiotic or D-amino acid was used as
positive control. Negative control (not shown in table) was LB medium without any antibiotic,
D-amino acid or bacterial cells.
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Table 4.5 Effect of D-amino acids given in conjunction with antibiotics in ΔdguA, ΔdauA,
and ΔdadA triple mutant.
MIC

1X
0.5X
0.25X

1X
0.5X
0.25X

1X
0.5X
0.25X

1X
0.5X
0.25X

PAO5434 (ΔdguA, ΔdauA, and ΔdadA)

Antibiotic
Carbenicillin
(µg/mL)
32
16
8
Carbenicillin
(µg/mL)
32
16
8
Gentamicin
(µg/mL)
8
4
2
Gentamicin
(µg/mL)
8
4
2

Ala
0.01
0.19
0.44

Val
0.13
0.22
0.51

Glu
0.20
0.28
0.43

Gln
0.12
0.16
0.37

His
0.00
0.21
0.36

Asn
0.00
0.25
0.52

Asp
0.01
0.41
0.59

Orn
0.06
0.47
0.77

Lys
0.00
0.22
0.55

Arg
0.04
0.16
0.56

Ser
0.07
0.30
0.63

Thr
0.01
0.28
0.64

Pro
0.10
0.44
0.69

Phe
0.42
0.27
0.58

Ala
0.00
0.10
0.30

Val
0.00
0.09
0.33

Glu
0.00
0.11
0.40

Gln
0.00
0.15
0.41

His
0.00
0.01
0.43

Asn
0.00
0.04
0.33

Asp
0.00
0.01
0.39

Orn
0.00
0.04
0.43

Lys
0.00
0.06
0.33

Arg
0.00
0.02
0.32

Ser
0.01
0.07
0.35

Thr
0.00
0.14
0.36

Pro
0.00
0.03
0.40

Phe
0.00
0.05
0.30

Positive
control
0.71
0.87
0.89
Positive
control
0.43
0.42
0.44
Positive
control
0.82
0.86
0.84
Positive
control
0.83
0.86
0.84

Tetracycline
Positive
(µg/mL)
Ala
Val
Glu
Gln
His
Asn
Asp
control
1X
8
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.93
0.5X
4
0.11
0.17
0.29
0.33
0.35
0.14
0.43
0.97
0.25X
2
0.49
0.49
0.49
0.50
0.58
0.53
0.43
0.92
Tetracycline
Positive
(µg/mL)
Orn
Lys
Arg
Ser
Thr
Pro
Phe
control
1X
8
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.95
0.5X
4
0.28
0.26
0.22
0.20
0.16
0.33
0.36
0.96
0.25X
2
0.48
0.51
0.44
0.47
0.54
0.50
0.38
0.95
4
About 5 x 10 CFU of ΔdguA, ΔdauA, and ΔdadA triple mutant cells were inoculated into LB
broth supplemented with 5 mM of various D-Amino acids in combination with 1X, 0.5X or
0.25X MIC of carbenicillin, gentamicin or tetracycline. The 96-well plates were incubated at 37
°C and growth was recorded by measuring OD600 24 h post inoculation. These results are an
average of two independent sets of culture under each condition. LB medium without any
antibiotic or D-amino acid was used as positive control. Negative control (not shown in table)
was LB medium without any antibiotic, D-amino acid or bacterial cells.
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4.4

Discussion
4.4.1

In vivo substrate specificity of the D-amino acid dehydrogenases.

The in vivo substrate specificity of the D-amino acid dehydrogenase is different from that
reported using in vitro studies.

Table 4.6 In vitro and in vivo substrate specificities of D-amino acid dehydrogenases.
Enzyme

Amino acids that

In vitro D-amino acid

In vivo D-amino acid

induce transcription

specificity of enzyme

utilization observed (this
study)

DguA

D-Glu, D-Gln

Glu, Gln, Pro

Glu, Gln, Ser

DadA

L-Ala, L-Val, L-Trp,

Ala, Arg, Asn, Asp, His, Leu,

Ala, Val, His, Lys, Arg,

L-Ser, L-Thr, L-Lys,

Lys, Met, Orn, Phe, Pro, Ser,

Ser, Pro, Met, Phe

L-Gly, L-Cys, D-Ala,

Thr, Trp, Tyr, Val

D-Thr
DauA

D-Arg, D-Lys

Arg, Lys, Met, Phe, Tyr, His,

His, Orn, Lys, Arg, Pro,

Orn, Leu, Trp, Val, Pro, Thr,

Met, Phe

Asn, Glu, Gln, Ala
The in vitro substrate specificities were pooled from previously published reports (19, 20, 33)
and the in vivo substrate specificities are from this study. The amino acids that are utilized by
each enzyme either only in vitro or in vivo are highlighted with a gray background. D-Trp and DTyr were not tested in vivo and hence not highlighted.

Purified His-tagged DguA was shown to utilize D-Glu, D-Gln and D-Pro in vitro (20). However,
in our study using in vivo gene complementation, it was found that DguA can utilize D-Glu, DGln, and D-Ser as substrates. DadA was shown to utilize 16 of the 18 D-amino acids tested in
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vitro (19). But, we found that in vivo substrate utilization by DadA is limited to D-Ala, D-Val,
D-His, D-Lys, D-Arg, D-Ser, D-Pro, D-Met, and D-Phe. Similarly, DauA was also shown to
utilize 9 D-amino acids very well, 9 other somewhat poorly (31). However, we found that DauA
can utilize D-His, D-Orn, D-Lys, D-Arg, D-Pro, D-Met, and D-Phe as substrates (see Table 4.7).
Overall, the enhanced growth on D-amino acids by the presence of recombinant clones was due
to increased levels of enzymes with broad substrate specificity. In the wild type strain,
expression of these enzymes is subjected to induction by specific D-amino acids or related
compounds. However, expression of these enzymes is constitutively active from the recombinant
clones.

4.4.2

Utilization of other D-amino acids.

If the wild type strain needed to convert D to L via the traditional racemase, then utilization of D
amino acids will not be affected in the triple mutant. Both the wild-type PAO1 and the ΔdguA,
ΔdauA, and ΔdadA triple mutant were able to utilize D-Gln as the sole source of carbon and
nitrogen while D-His, Asn, Ser, Thr, Met and Phe served only as a nitrogen source. D-Glutamine
degradation can proceed in two possible ways: it can be converted into the L-form by a racemase
or it can be directly deaminated to form glutamate and ammonia. In the case of the triple mutant,
since D-glutamate degradation is abolished (requires DguA), I presumed that D-Gln is being
converted into L-Gln by an unknown racemase followed by deamination to form L-Glu (a good
carbon and nitrogen source for PAO1) and ammonia. However, enhanced growth by dguA gene
complementation suggests that the alternate route is also possible. The utilization of D-Asn could
be following similar suite. Both L-Gln and L-Asn can be deaminated by the glutaminase and
asparaginase enzymes to remove the amine group and produce L-Glu and L-Asp respectively.
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Both these enzymes have been previously detected and purified from Pseudomonads and PAO1
has two genes (ansA and ansB) that have high sequence similarity to the glutaminase and
asparaginase enzymes (59, 11, 12). Utilization of D-Ser and D-Thr can be attributed to D-Ser
dehydratase even though dadA gene complementation enhanced growth on D-Ser as nitrogen. In
E. coli, D-Met was suggested to be converted into keto-methionine and then into L-Met (9). The
arginine: pyruvate transaminase AruH of P. aeruginosa PAO1 was shown to utilize L-Met as a
substrate (64). Even though not studied experimentally, it is possible that AruH is responsible for
the utilization of D-Met as a nitrogen source in the triple mutant. However, as demonstrated by
others previously we also observed an enhanced growth on D-Met when complemented by dadA
and dauA genes. In case of D-His, even though dadA and dauA gene complementation seemed to
contribute to its utilization as a nitrogen source, there are other unknown enzymes that we are not
aware of allowing the triple mutant to harvest nitrogen from D-His. The wild-type and ΔdguA,
ΔdauA, and ΔdadA triple mutant strains were able to utilize D-Phe as only a nitrogen source
indicating the involvement of another unknown enzyme. dadA and dauA or dauAB gene
complementation allowed the triple mutant to utilize D-Phe as both carbon and nitrogen sources
confirming previous reports (19, 31). The wild-type PAO1 was also able to utilize D-Pro as a
nitrogen source which was completely abolished in the ΔdguA, ΔdauA, and ΔdadA triple mutant.
Complementation with any of the three dehydrogenase genes did not restore the utilization of DPro. D-Pro utilization was shown to be dependent on the dpkA gene in P. putida. Since the dpkA
gene was not mutated, it is not clear as to why the utilization D-Pro was abolished in the ΔdguA,
ΔdauA, and ΔdadA triple mutant (38).
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4.4.3

The triple mutant is weakened by an unknown mechanism.

The triple dehydrogenase mutant is weakened by an unknown mechanism. As a result, the triple
mutant exhibited increased susceptibility to some of the common laboratory antibiotics. Both for
Carbenicillin and tetracycline, the triple mutant had two-fold lower MIC than the wild-type
PAO1. The mechanism by which the loss of dauA, dadA, and dguA genes affects the cell is yet to
be studied. This might pave way for better strategies to combat P. aeruginosa infections.

4.4.4

No special synergy was observed between D-amino acids and antibiotics
against the triple mutant.

Previous studies by other groups showed that D-amino acids can be detrimental to the cell and
exhibit synergy with β-lactam antibiotics (3, 52). A mixture of D-amino acids was shown to
prevent biofilm formation (26) and modify cell wall (28). In addition, excessive D-amino acids in
the cell if not effectively removed or utilized, can also be wrongly charged on the tRNA’s and
there by stall protein synthesis. We hypothesized that deletion of all the three D-amino acid
dehydrogenases would weaken the cell or make it more resistant. We also hypothesized that the
addition of D-amino acids to the triple mutant in combination with antibiotics would have a
synergistic or antagonistic effect in inhibiting the growth of PAO1. True to our hypothesis, we did
observe that the triple mutant had lowered tolerance for antibiotics compared to the wild-type
PAO1. When the cells were exposed to 1X MIC of carbenicillin, presence of D-Phe and D-Pro
resulted in cell growth in both the wild-type PAO1 and the ΔdguA, ΔdauA, and ΔdadA triple
mutant. In the case of gentamicin and tetracycline, the presence of D-amino acids made the cells
more susceptible to these antibiotics. Complete growth inhibition was observed even at 0.5X MIC
when gentamicin was given in combination with any of the D-amino acids tested. In the case of
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tetracycline, a significant growth reduction was noted at 0.5X and 0.25X MIC when given in
combination with any of the D-amino acids tested. This synergy between gentamycin or
tetracycline and D-amino acids was noted in both the wild-type and the ΔdguA, ΔdauA, and ΔdadA
triple mutant cells. However, no special synergistic or antagonistic effects were observed
specifically in the ΔdguA, ΔdauA, and ΔdadA triple mutant as compared to the wild-type PAO1
when D-amino acids were given in combination with antibiotics.
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5

GENERAL CONCLUSION

P. aeruginosa, an opportunistic human pathogen, is also well known for its enormous metabolic
capacity making it a model organism to study nutrient utilization genes and pathways. In
addition, owing to its resistance to multiple antibiotics, the pursuit of new targets for potential
antibiotic development has been of great interest in this organism. In this dissertation, we studied
the lysine catabolic pathway to identify the missing players. We have shown that the gcdGH
genes encoding glutaryl-CoA dehydrogenase and as putative acyl-CoA transferase, respectively,
are essential for lysine catabolism. Transcription of this operon is activated by GcdR in the
presence of glutarate and we showed the possible GcdR binding site on the gcdH promoter DNA.
Though glutarate is an intermediate compound of L-lysine catabolism, the gcdG and gcdH
mutants cannot grow on L-Pip, a D-lysine metabolite, suggesting that L-Pip is also degraded via
glutarate. This is the first link indicating that L-and D-lysine catabolic pathways are connected.
We further showed that PA2035 is induced by D-Lys and L-pip and mutants of this gene cannot
grow on L-Pip. We believe that PA2035 encoding a TPP-dependent decarboxylase is a possible
player in the conversion of 2-aminoadipate to glutarate.

There are multiple reasons that possibly contribute to lysine being a poor nutrient source in P.
aeruginosa PAO1. Previous studies from our lab showed that lysine decarboxylase enzyme ldcA,
the first enzyme in L-lys catabolism, is under the control of an arginine-responsive transcriptional
regulator argR. In this study, we showed that lysine uptake and export are two other bottlenecks
for growth on L-Lys. We found the lysXE operon encoding an uncharacterized protein and a
putative lysine efflux protein is induced by exogenous L-Lys. This operon is under the
transcriptional regulation of LysR and we have identified the LysR operator site on lysX promoter
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DNA. Knockout mutants of lysR, lysX, and lysE were found to grow much better than the wildtype PAO1 on MMP agar with L-Lys as the sole source of C & N and had a much shorter lagphase and generation time in liquid media. We believe that the shorter lag phase and generation
time observed in lysR, lysX, and lysE mutants was due to the lack of a functional lysine exporter,
resulting in a higher intracellular concentrations of L-Lys compared to the wild-type PAO1. In this
study, we also showed that lysP mutant grew very poorly on L-lys compared to the wild type
PAO1. Transcription of the lysP gene is positively regulated by aruSR that responds to L-Lys and
L-Arg and negatively regulated by argR that responds to L-Arg making this another bottleneck for
lysine catabolism. P. aeruginosa is well equipped to grow more efficiently on Arg than on Lys,
with the ArgR regulator in response to L-Arg as the major player to control the entire arginine
network. The physiological significance of this observed nutritional preference for Arg over Lys
in Pseudomonas was a very intriguing question for future investigation.

Previous studies from our lab showed that catabolic and anabolic dehydrogenases DauA and DauB
are essential for D-to-L racemization of arginine which is a prerequisite for D-arginine utilization
in P. aeruginosa PAO1. In addition to D-arginine, DauA can utilize D-Lys as a substrate to
generate keto lysine or α-keto-ε-aminohexanoate which can further be degraded into L-Pip and so
on. In this dissertation, we studied the substrate specificity of DauB to see if D-Lys can be
racemized to L-Lys for catabolism. We also studied the enzyme kinetics of DauB. Using a reverse
reaction to measure DauB activity, we found that DauB showed little or no activity against lysine
or other L-amino acids as substrates as compared to that against L-Arg (taken as 100 %). This
indicates that DauB is an arginine-specific dehydrogenase unlike its partner enzyme DauA
eliminating the possibility of D-to-L racemization of Lysine for catabolism (there is no other lysine
racemase in PAO1).
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In bacteria, D-amino acids are formed by racemization from cognate L-enantiomers which is an
energetically expensive process for the cell. P. aeruginosa PAO1 has three known D-amino acid
dehydrogenases: dadA, dauA, and dguA. The in vitro substrate specificity of these three enzymes
has been demonstrated by our lab previously. However, we do not know if these results are true
and the only physiological functions of these enzymes. With the emerging understanding of the
far more important functions of D-amino acids and some of these D-amino acid catabolizing genes
in the bacterial world, it is intriguing to see if the D-amino acid dehydrogenase genes/enzymes
also have a wider physiological implication. We hypothesized that the lack of dadA, dauA, and
dguA genes might weaken the cell and make it more susceptible to antibiotics when given in
combination with D-amino acids. We also tested the role of each of these dehydrogenases in the
utilization of various D-amino acids in vivo. We found that the in vivo substrate specificity of the
D-amino acid dehydrogenases is different from that reported using in vitro studies.

The ΔdguA, ΔdauA, and ΔdadA triple dehydrogenase mutant is weakened by an unknown
mechanism resulting in increased susceptibility to carbenicillin and tetracycline. The mechanism
by which the loss of dauA, dadA and dguA genes affects the cell is yet to be studied. This might
pave the way for better strategies to combat P. aeruginosa infections. At concentrations below
the MIC, synergy was observed between gentamicin or tetracycline and D-amino acids resulting
in growth inhibition or reduction, in the wild-type PAO1 and the ΔdguA, ΔdauA, and ΔdadA
triple mutant, respectively. However, no special synergistic or antagonistic effects were observed
specifically in the ΔdguA, ΔdauA and ΔdadA triple mutant as compared to the wild-type PAO1
when D-amino acids were given in combination with antibiotics.
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